SlideShare una empresa de Scribd logo
1 de 220
Descargar para leer sin conexión
Autoimmune Disorders Part I:
 Rheumatoid Arthritis, Osteoarthritis, &
           Gouty Arthritis


     Maria Carmela L. Domocmat, RN, MSN
           Instructor, School of Nursing
         Northern Luzon Adventist College
IMMUNE TOLERANCE:
ability to recognize or distinguish self (self-
antigens) from non-self (foreign antigens) like
bacteria or viruses.
immune system is tolerant to the host‘s tissues
but is able to reject foreign tissues and destroy
infectious agents.
Autoimmune Disorders
failure of the tolerance mechanism
immune reaction against self-antigens
usually occurs after destruction of some of the
body‘s tissues  release of ‗self antigens‘ that
circulate in the body  acquired immunity
(activated T cells or antibodies)




              Maria Carmela L. Domocmat, RN, MSN
Why does the immune system attack the body that
it‘s supposed to protect?
 Failure to recognize some cells as ―self‖
    in rheumatic fever, the streptococcus antigen is very similar to a
    protein in heart tissue, so the body mistakenly identifies heart
    tissues as foreign

 When the immune system sees ―self‖ antigens as ―nonself‖
    cells seen as foreign are attacked and destroyed
    may be only a few select cells or organs (organ-specific) – e.g.,
    multiple sclerosis, juvenile diabetes, rheumatic fever
    may be systemic - e.g., systemic lupus erythematosus, rheumatoid
    arthritis




                     Maria Carmela L. Domocmat, RN, MSN
Autoimmune Disorders
Incidence
  ~ 3.5 % of people have autoimmune diseases
  On average, women are 2.7 times more likely to
  develop these diseases than men




               Maria Carmela L. Domocmat, RN, MSN
Autoimmune Disorders
Cause:
  most have no known cause
  may be due to genetic factors, infectious agents,
  gender, and age
Effect:
  The autoimmune response results in tissue damage
  Some damage occurs in only one or a few organs, in
  other cases it may be body-wide (systemic)




                Maria Carmela L. Domocmat, RN, MSN
Autoimmune Disorders
Treatment
  No Cure
  Symptomatic treatment




             Maria Carmela L. Domocmat, RN, MSN
CONNECTIVE TISSUE: A
REVIEW

       Maria Carmela L. Domocmat, RN, MSN
Connective tissue
is a type of tissue made up of fibers forming a
framework and support structure for body
tissues and organs.




              Maria Carmela L. Domocmat, RN, MSN
Connective tissue
is the material between the cells of the body that
gives tissues form and strength.
This "cellular glue" is also involved in delivering
nutrients to the tissue, and in the special
functioning of certain tissues.
surrounds many organs.
  Cartilage, blood and bone are specialized forms of connective
  tissue.




                 Maria Carmela L. Domocmat, RN, MSN
Connective tissue
is made up of dozens of proteins,
including:
  collagens (a fibrous protein building block)
  proteoglycans (a group of proteins that maintain
  tissue stiffness)
  glycoproteins (composed of a protein and a sugar)
  The combination of these proteins can vary between
  tissues.




              Maria Carmela L. Domocmat, RN, MSN
Connective tissue disorders (CTD)
Is the major focus of rheumatology
  The study of rheumatic disease
rheumatic disease
  is any disease or condition involving the
  musculoskeletal system
CTDs are discussed separately from other
musculoskeletal disorders bcoz most CTDs are
classified as autoimmune disorders



               Maria Carmela L. Domocmat, RN, MSN
Connective tissue disorders (CTD)
Many rheumatic related                 Dermatomyositis
conditions are also                    Polymyositis
connective tissue disorders            Bursitis
including:
                                       Vasculitis
Lupus (Systemic Lupus
Erythematosus)                         Polymyalgia rheumatica
Psoriasis                              Giant Cell Arteritis
Scleroderma (Systemic                  Mixed Connective Tissue
Sclerosis)                             Disease (MCTD)
Ankylosing Spondylosis                 Lyme disease
Reactive Arthritis                     Sarcoidosis
Fibromyalgia

                 Maria Carmela L. Domocmat, RN, MSN
Rheumatic diseases or disorders
Comprise autoimmune and inflammatory
disorders
‗the primary crippling disease‖




            Maria Carmela L. Domocmat, RN, MSN
Rheumatic diseases or disorders
Primary reason for work-related disability
Leading cause of disability among 65 yrs old
and above

More than 40M in US have at least 1 of more
than 100 types of arthritis
  Arthritis – means inflammation of one or more joints




               Maria Carmela L. Domocmat, RN, MSN
Maria Carmela L. Domocmat, RN, MSN
Rheumatoid Arthritis (RA)

chronic systemic autoimmune disease
 - anti-self antibodies that react with the constant regions of other
   antibodies (rheumatoid factor)
onset of disease occurs most often between the ages of
25-55
   women are 3 times more likely to develop this than men
symptoms include weakness, fatigue, and joint pain
infections, hormones and genetic factors may be involved
      X-ray shows severe arthritis
      affecting the joints and
      limiting mobility




                        Maria Carmela L. Domocmat, RN, MSN
Rheumatoid arthritis (RA) affects peripheral
joints and may cause destruction of both cartilage
and bone. The disease affects mainly individuals
carrying the DR4 variant of MHC genes.




              Maria Carmela L. Domocmat, RN, MSN
Treatment




Maria Carmela L. Domocmat, RN, MSN
Maria Carmela L. Domocmat, RN, MSN
Maria Carmela L. Domocmat, RN, MSN
Maria Carmela L. Domocmat, RN, MSN
ACR Clinical Classification
Criteria for Rheumatoid Arthritis
using history, physical examination, laboratory
and radiographic findings:




              Maria Carmela L. Domocmat, RN, MSN
ACR Clinical Classification
Criteria for Rheumatoid Arthritis




          Maria Carmela L. Domocmat, RN, MSN
Maria Carmela L. Domocmat, RN, MSN
http://img.medscape.com/slide/migrated/editorial/cmecircle/2004/3415/images/moreland/slide07.gif
                                        Maria Carmela L. Domocmat, RN, MSN
Maria Carmela L. Domocmat, RN, MSN
Maria Carmela L. Domocmat, RN, MSN
Maria Carmela L. Domocmat, RN, MSN
Maria Carmela L. Domocmat, RN, MSN
Maria Carmela L. Domocmat, RN, MSN
Initial Laboratory work-up
Complete blood count
Comprehensive metabolic panel
Urinalysis
Sedimentation Rate
Rheumatoid Factor
Anti-nuclear Antibody




            Maria Carmela L. Domocmat, RN, MSN
Maria Carmela L. Domocmat, RN, MSN
Other diagnostic tests
Radiologic exam
  X-ray, Bone scan or joint scan, MRI
  Help confirm disease activity and monitor treatment
  results
  Early stage: Increased shadowing around the affected
  joint: indicates soft tissue swelling




              Maria Carmela L. Domocmat, RN, MSN
Radiology
early in the disease
  show nothing other than soft tissue swelling.
periarticular osteopenia may develop.
With progression of disease
  narrowing of the joint space is caused by loss of
  cartilage, and juxta-articular erosions appear, generally
  at the point of attachment of the synovium.
end-stage disease
  large cystic erosions of bone may be seen. Bony
  proliferation may occur because of degenerative
  changes that follow inflammation.
                Maria Carmela L. Domocmat, RN, MSN
Other diagnostic tests
Arthrocentesis
  Aspirate sample of synovial fluid; analyzed for inflam
  cells and immune complexes
     Synovial fluid is milky, cloudy, or dark yellow fluid (normal:
     transparent)
     Arthroscopic examination: show pale, thick, edematous
     synovial villi, cartilage destruction, and fibrous scar formation
     (pannus)
     Nrg care: use ice and rest the affected joint for 24 hrs
     Acetaminophen




                 Maria Carmela L. Domocmat, RN, MSN
Clinical manifestations




    Maria Carmela L. Domocmat, RN, MSN
Maria Carmela L. Domocmat, RN, MSN
http://nobelprize.org/medicine/laureates/1996/illpres/implications.html


Maria Carmela L. Domocmat, RN, MSN
Maria Carmela L. Domocmat, RN, MSN
Maria Carmela L. Domocmat, RN, MSN
Typical visible changes
include ulnar deviation of
the fingers at the MCP
joints, hyperextension or
hyperflexion of the MCP
and PIP joints, flexion
contractures of the
elbows, and subluxation
of the carpal bones and
toes (cocked -up).




                 Maria Carmela L. Domocmat, RN, MSN
Extra-Articular Disease
Rheumatoid Nodules
Cardiopulmonary Disease
Ocular Disease
Neurologic Disease
Felty's Syndrome
Rheumatoid Vasculitis
Sjogren's Syndrome



            Maria Carmela L. Domocmat, RN, MSN
Rheumatoid Nodules
subcutaneous nodule
 the most characteristic extra-articular lesion of the
 disease.
 occur in 20 to 30% of cases, almost exclusively in
 seropositive patients.
 located most commonly on the extensor surfaces of the
 arms and elbows but are also prone to develop at
 pressure points on the feet and knees.




              Maria Carmela L. Domocmat, RN, MSN
Rheumatoid Nodules




               http://images.rheumatology.org/vi
               ewphoto.php?imageId=3011201
               &albumId=75692




   Maria Carmela L. Domocmat, RN, MSN
Rheumatoid Nodules
                         commonly form near
                         extensor surface of elbow

                         can be fixed to underlying
                         periosteum or can be
                         freely mobile.




   Maria Carmela L. Domocmat, RN, MSN
Cardiopulmonary Disease
There are several pulmonary manifestations
  including pleurisy with or without effusion,
  intrapulmonary nodules,
  rheumatoid pneumoconiosis (Caplan's syndrome),
  diffuse interstitial fibrosis, and rarely,
  bronchiolitis obliterans pneumothorax.




              Maria Carmela L. Domocmat, RN, MSN
Caplan‘s Syndrome
    Presence of rheumatoid nodules in lungs
    pneumococcus (noted in among coal miners and
    asbestos workers)




http://images.rheumatology.
org/image_dir/album75692/
md_99-05-0096_1.tif.jpg

                              Maria Carmela L. Domocmat, RN, MSN
Cardiopulmonary Disease
Pericarditis is the most common cardiac
manifestation.




              Maria Carmela L. Domocmat, RN, MSN
Neurologic Disease
most common - mild, primarily sensory peripheral
neuropathy, usually more marked in the lower
extremities.
Entrapment neuropathies (e.g., carpal tunnel
syndrome and tarsal tunnel syndrome) sometimes
occur because of compression of a peripheral
nerve by inflamed edematous tissue.




              Maria Carmela L. Domocmat, RN, MSN
Neurologic Disease
Cervical myelopathy secondary to atlantoaxial
subluxation (partial dislocation) is an uncommon
but particularly worrisome complication potentially
causing permanent, even fatal neurologic
damage.




               Maria Carmela L. Domocmat, RN, MSN
Felty's Syndrome
is characterized by splenomegaly, leukopenia -
predominantly Granulocytopenia and leg ulcers
rare complication
Recurrent bacterial infections and chronic
refractory leg ulcers are the major complications.




               Maria Carmela L. Domocmat, RN, MSN
Rheumatoid Vasculitis
most common clinical manifestations a
small digital infarcts along the nailbeds.




               Maria Carmela L. Domocmat, RN, MSN
Sjogren's Syndrome
• is the most common ocular manifestation of
  rheumatoid arthritis.
  Autoimmune destruction of the lacrimal, salivary
  and vaginal mucus producing glands
         which leads to impaired secretion of saliva
      and tears and results in the sicca complex:
       dry mouth (xerostomia)
       dry eyes (keratoconjunctivitis sicca)
       dry vagina (rare)


                  Maria Carmela L. Domocmat, RN, MSN
Sjogren's Syndrome
Associated with RA and fibromyalgia
Insufficient tears cause inflammation and
ulceration of the cornea
insufficient saliva cause decreased digestion of
CHO, promotes tooth decay and increases
incidence of infections
Vaginal dryness cause infection and
dyspareunia
NO CURE!!!

             Maria Carmela L. Domocmat, RN, MSN
Criteria for Diagnosis of Sjögren's Syndrome


Four or
more of
the
following
criteria
must be
present




              Maria Carmela L. Domocmat, RN, MSN
Keratoconjunctivitis, Sicca




      Maria Carmela L. Domocmat, RN, MSN
PROGNOSIS


      Maria Carmela L. Domocmat, RN, MSN
Disability is higher among patients with
rheumatoid arthritis with 60% being unable to
work 10 years after the onset of their disease.
Recent studies have demonstrated an increased
mortality in rheumatoid patients.
Median life expectancy was shortened an average
of 7 years for men and 3 years for women
compared to control populations.



             Maria Carmela L. Domocmat, RN, MSN
Patients at higher risk for shortened survival are
those with
  systemic extra-articular involvement,
  low functional capacity,
  low socioeconomic status,
  low education, and
  prednisone use.




                Maria Carmela L. Domocmat, RN, MSN
ACR Guidelines for Medical
Management of Rheumatoid
        Arthritis
      (updated April, 2002)
Maria Carmela L. Domocmat, RN, MSN
Management




Maria Carmela L. Domocmat, RN, MSN
goals of treatment
aim toward achieving the
  lowest possible level of arthritis disease activity
  and remission if possible,
  the minimization of joint damage, and
  enhancing physical function and quality of life.




                  Maria Carmela L. Domocmat, RN, MSN
 Reduce pain and inflammation
 Protect Articular surface
    › Reduction of joint stress
   Maintain function
    › ROM exercises
    › Physical and occupational therapy
   Surgical intervention



             Maria Carmela L. Domocmat, RN, MSN
REDUCE PAIN AND
INFLAMMATION

       Maria Carmela L. Domocmat, RN, MSN
Pharmacologic treatment
1. Non-steroidal Anti-inflammatory Agents
   (NSAIDs)
2. Disease Modifying Anti-rheumatic Drugs
   (DMARDs)
3. Corticosteroids




              Maria Carmela L. Domocmat, RN, MSN
NSAIDs and corticosteroids
have a short onset of action while DMARDs can
take several weeks or months to demonstrate a
clinical effect




             Maria Carmela L. Domocmat, RN, MSN
NON-STEROIDAL ANTI-
INFLAMMATORY AGENTS
(NSAIDS)
      Maria Carmela L. Domocmat, RN, MSN
NSAIDs
major effect - reduce acute inflammation thereby
decreasing pain and improving function.
have mild to moderate analgesic properties
independent of their anti-inflammatory effect.
Note: these drugs alone do not change the course
of the disease of rheumatoid arthritis or prevent
joint destruction.




              Maria Carmela L. Domocmat, RN, MSN
OTC NSAIDs
Aspirin
ibuprofen (Advil ®, Motrin®, Nuprin ®)
naproxen (Alleve®, Flanax)
ketoprofen (Actron, Orudis KT)




             Maria Carmela L. Domocmat, RN, MSN
Aspirin - oldest drug of the non-steroidal class
  but because of its high rate of GI toxicity, a narrow
  window between toxic and anti-inflammatory serum
  levels, and the inconvenience of multiple daily doses,
  aspirin's use as the initial choice of drug therapy
  has largely been replaced by other NSAIDs.




                Maria Carmela L. Domocmat, RN, MSN
Prescription NSAIDs include

meloxicam (Mobic®),                    diclofenac (Cataflam®,
etodolac (Lodine®),                    Voltaren®, Arthrotec®),
nabumetone (Relafen®),                 diflusinal (Dolobid®),
sulindac (Clinoril®),                  indomethicin (Indocin®),
tolementin (Tolectin®),                ketoprofen (Orudis®,
choline magnesium                      Oruvail®),
salicylate (Trilasate®),               oxaprozin (Daypro®),
flurbiprofen (Ansaid),                 piroxicam (Feldene®).
dexibuprofen (Seractil)



                Maria Carmela L. Domocmat, RN, MSN
Beware of NSAID-induced ulcers




        Maria Carmela L. Domocmat, RN, MSN
How to Prevent NSAID-Induced
           Ulcers
If NSAID-induced ulcers are identified, the
following steps have been suggested:
Switch to alternative pain relievers.
  proton-pump inhibitors (PPIs).
  misoprostol or Arthrotec.
  L-arginine
If cannot change drugs, then should use lowest
NSAID dose possible



               Maria Carmela L. Domocmat, RN, MSN
Prevention NSAID-Induced Ulcers
proton-pump inhibitors (PPIs).
  Can reduce NSAID-ulcer rates by as much as 80%
  compared with no treatment.
  omeprazole (Prilosec)
  esomeprazole (Nexium)
  lansoprazole (Prevacid),
  rabeprazole (Aciphex),
  pantoprozole (Protonix).




             Maria Carmela L. Domocmat, RN, MSN
Prevention NSAID-Induced Ulcers
Try misoprostol or Arthrotec.
   If other agents are inappropriate, misoprostol protects against
   the major intestinal toxicity of NSAIDs.
   the first drug approved for preventing NSAID-induced ulcers.
   It is equally or even more effective than some of the PPIs, but it
   does not heal existing ulcers and has more side effects than
   PPIs. Patients tend to stop using it.
Arthrotec - a combination of an ulcer protective
agent called misoprostol and the NSAID
diclofenac.


                   Maria Carmela L. Domocmat, RN, MSN
L-arginine supplement
  an amino acid found in health stores
  may help protect against damage from NSAIDs.
  an alternative agent
  not government regulated and more research is
  needed to confirm its benefits.




              Maria Carmela L. Domocmat, RN, MSN
Topical NSAIDs
delivered in gels, creams, or patches are proving
to reduce arthritic pain and pose less of a risk for
gastrointestinal complications associated with
oral NSAIDs.
diclofenac (Pennsaid, Oxa Sat)
eltenac, ibuprofen, or ketoprofen.




              Maria Carmela L. Domocmat, RN, MSN
$63.07
Maria Carmela L. Domocmat, RN, MSN
NSAIDS: COX-2 inhibitor
includes COX-2 inhibitors
also effective in controlling inflammation.
Only one of these agents is currently available in
the United States (celecoxib, Celebrex®) while
additional compounds are available in other
countries (etoricoxib, Arcoxia®; lumiracoxib,
Prexige®).




               Maria Carmela L. Domocmat, RN, MSN
or COX-2 medications




            Maria Carmela L. Domocmat, RN, MSN
COX-2 inhibitors
 designed to decrease the gastrointestinal risk of
 NSAIDS,
 but concerns of possible increases in
 cardiovascular risk with these agents has led to
 the withdrawal of two of these drugs from the
 market (rofecoxib, Vioxx®; valdecoxib, Bextra®).




                Maria Carmela L. Domocmat, RN, MSN
CORTICOSTEROIDS


      Maria Carmela L. Domocmat, RN, MSN
Corticosteroids
anti-inflammatory & immunoregulatory activity.
PO, IV, IM or can be injected directly into the joint.
useful in early disease as temporary adjunctive
therapy while waiting for DMARDs to exert their
antiinflammatory effects.




               Maria Carmela L. Domocmat, RN, MSN
Corticosteroids




 Maria Carmela L. Domocmat, RN, MSN
Corticosteroids
also useful as chronic adjunctive therapy in
patients with severe disease that is not well
controlled on NSAIDs and DMARDs.

Weight gain and a cushingoid appearance
(increased fat deposition around the face, redness
of the cheeks, development of a ―buffalo hump‖
over the neck) is a frequent problem and source of
patient complaints


               Maria Carmela L. Domocmat, RN, MSN
cushingoid appearance




    Maria Carmela L. Domocmat, RN, MSN
Prevent osteoporosis due to steroid
               use
adequate calcium and vitamin D supplementation
Bisphosphonates
  alendronate (Fosamax®)
  risedronate (Actonel®)
  ibandronate (Boniva®)
Patients with and without osteoporosis risk factors
on low dose prednisone should undergo bone
densitometry (DEXA Scan) to assess fracture risk.



              Maria Carmela L. Domocmat, RN, MSN
Intra-articular corticosteroids
  (e.g., triamcinolone or
  methylprednisolone and others)
 are effective for controlling a local
flare in a joint without changing the
overall drug regimen.




                Maria Carmela L. Domocmat, RN, MSN
http://www.mayoclinicproceedings.com/content/84/9/831.full
                                   Maria Carmela L. Domocmat, RN, MSN
DISEASE MODIFYING ANTI-
RHEUMATIC DRUGS
(DMARDS)
       Maria Carmela L. Domocmat, RN, MSN
Disease Modifying Anti-rheumatic
       Drugs (DMARDs)
Can alter the disease course and improve
radiographic outcomes.
DMARDs have an effect upon rheumatoid arthritis
that is different and may be more delayed in onset
than either NSAIDs or corticosteroids.
when the diagnosis of rheumatoid arthritis is
confirmed, DMARD agents should be started.




              Maria Carmela L. Domocmat, RN, MSN
DMARDs
Methotrexate (Rheumatrex®, Trexall®)
Hydroxychloroquine (Plaquenil ®)
Sulfasalazine (Azulfidine®)
Tumor Necrosis Factor Inhibitors
  etanercept (Enbrel®
  adalimumab (Humira ®)
  infliximab (Remicade®)
  Leflunomide (Arava®)
T-cell Costimulatory Blocking Agents
  abatacept (Orencia®)
               Maria Carmela L. Domocmat, RN, MSN
DMARDs
B cell Depleting Agents
  rituximab (Rituxan®)
Interleukin-1 (IL-1) Receptor Antagonist Therapy
  anakinra (Kineret®)
Intramuscular Gold
Other Immunomodulatory and Cytotoxic agents—
  azathioprine (Imuran®),
  cyclophosphamide, and
  cyclosporine A(Neoral®, Sandimmune®)


               Maria Carmela L. Domocmat, RN, MSN
Nursing Mgmt
Note: DMARDs are toxic to multiple body organs
including liver, kidneys, GIT, lungs, bone
marrow, eyes, and must be monitored closely
These drugs suppress the bone marrow and
place clients at risk for infection, anemia, and
bleeding




             Maria Carmela L. Domocmat, RN, MSN
Methotrexate
the first-line DMARD agent
Has rapid onset of action at therapeutic doses (6-
8 weeks)
good efficacy
favorable toxicity profile
ease of administration
and relatively low cost.



              Maria Carmela L. Domocmat, RN, MSN
http://www.muabannhadat123.com/forum/showthread.php?p=3477

Maria Carmela L. Domocmat, RN, MSN
Hydroxychloroquine
an antimalarial drug
relatively safe and well-tolerated agent for the
treatment of rheumatoid arthritis.
have limited ability to prevent joint damage on
their own, their use should probably be limited to
patients with very mild and nonerosive disease.




               Maria Carmela L. Domocmat, RN, MSN
Hydroxychloroquine
is sometimes combined with methotrexate for
additive benefits for signs and symptoms or as
part of a regimen of ―triple therapy‖ with
methotrexate and sulfasalazine.




              Maria Carmela L. Domocmat, RN, MSN
Sulfasalazine
 Azulfidine®
effectiveness - somewhat less than
that methotrexate,
reduce signs and symptoms and
slow radiographic damage.
given in conjunction with
methotrexate and
hydroxychloroquine as part of a
regimen of ―triple therapy‖

              Maria Carmela L. Domocmat, RN, MSN
Leflunomide (Arava®)
efficacy is similar to methotrexate in terms of signs
and symptoms
viable alternative - failed or are intolerant to
methotrexate.




               Maria Carmela L. Domocmat, RN, MSN
Tumor necrosis factor (TNF)
           inhibitors
Tumor necrosis factor alpha (TNF)
  is a pro-inflammatory cytokine produced by
  macrophages and lymphocytes.
  found in large quantities in the rheumatoid joint and is
  produced locally in the joint by synovial macrophages
  and lymphocytes infiltrating the joint synovium.
  TNF is one of the critical cytokines that mediate joint
  damage and destruction due to its activities on many
  cells in the joint as well as effects on other organs and
  body systems.


                Maria Carmela L. Domocmat, RN, MSN
TNF antagonists
first of the biological DMARDS to be approved for
the treatment of RA
have also been referred to as biological
response modifiers or “biologics” to
differentiate them from other DMARDS such as
methotrexate, leflunomide, or sulfasalazine.




              Maria Carmela L. Domocmat, RN, MSN
TNFs or Biological Response
       Modifiers (BRMs)
Etanercept (Enbrel®)
Infliximab(Remicade®)
Adalimumab (Humira®)




            Maria Carmela L. Domocmat, RN, MSN
Etanercept (Enbrel®)
Etanercept is effective in reducing the signs and
symptoms of RA, as well as in slowing or halting
radiographic damage, when used either as
monotherapy or in combination with methotrexate.




              Maria Carmela L. Domocmat, RN, MSN
Infliximab(Remicade®)
Infliximab, in combination with methotrexate, is
approved for the treatment of RA, and for the
treatment of psoriatic arthritis, and ankylosing
spondylitis, as well as psoriasis and Crohn‘s
disease.




               Maria Carmela L. Domocmat, RN, MSN
Adalimumab (Humira®)
Adalimumab is a fully human anti-TNF monoclonal
antibody with high specificity for TNF.




             Maria Carmela L. Domocmat, RN, MSN
Anakinra (Kineret™)
a human recombinant IL-1 receptor antagonist (hu
rIL-1ra)
can be used alone or in combination with
DMARDs other than TNF blocking agents
(Etanercept, Infliximab, Adalimumab).




              Maria Carmela L. Domocmat, RN, MSN
T-cell Costimulatory blockade
Abatacept (Orencia®)
first of a class of agents known as T-cell
costimulatory blockers.
interfere with the interactions between antigen-
presenting cells and T lymphocytes and affect
early stages in the pathogenic cascade of events
in rheumatoid arthritis.




              Maria Carmela L. Domocmat, RN, MSN
Intramuscular Gold
Myochrysine® and Solganal®
IM
have been replaced by
Methotrexate and other DMARDS
as the preferred agents to treat RA.
rarely used now due to their
numerous side effects and
monitoring requirements, their
limited efficacy, and very slow
onset of action.
              Maria Carmela L. Domocmat, RN, MSN
Plasmapheresis




 Maria Carmela L. Domocmat, RN, MSN
Alternative treatments
  glucosamine sulfate
  chondroitin sulfate
   are dietary supplements usually taken in pill form that
  are thought to protect and possibly help repair
  cartilage cells.




               Maria Carmela L. Domocmat, RN, MSN
NURSING MANAGEMENT


      Maria Carmela L. Domocmat, RN, MSN
Chronic pain r/t inflammation and swelling from
pressure on surrounding tissues, joint deformity
and joint destruction
  Teach about meds
  Promote comfort with nonpharmacologic measures
  Manage stiffness
  Promote sleep and rest




             Maria Carmela L. Domocmat, RN, MSN
Promote comfort with
nonpharmacologic measures




       Maria Carmela L. Domocmat, RN, MSN
Manage stiffness




 Maria Carmela L. Domocmat, RN, MSN
Promote sleep and rest
Encourage to sleep at least 8 hrs at night, take
daily naps
Promote a quiet envt
Provide warm beverages before retiring to sleep
Administer hypnotics or relaxants as prescribed




             Maria Carmela L. Domocmat, RN, MSN
REDUCTION OF JOINT
STRESS

       Maria Carmela L. Domocmat, RN, MSN
Reduction of joint stress
Because obesity stresses the musculoskeletal
system, ideal body weight should be achieved and
maintained.
Rest, in general, is an important feature of
management.
When the joints are actively inflamed, vigorous
activity should be avoided because of the danger
of intensifying joint inflammation or causing
traumatic injury to structures weakened by
inflammation.

             Maria Carmela L. Domocmat, RN, MSN
Readiness for enhanced self-care r/t complex
medication schedules, high risk of S/E of meds,
health maintenance, and self-care
  Promote balanced diet
  Promote decision-making
  Promote hope
  Promote coping




             Maria Carmela L. Domocmat, RN, MSN
Self-care
Use china or heavy plastic cup with handle
which is easier to manipulate rather than
styrofoam or paper cup which may bend or
collapse
When fine motor activities become impossible –
use larger joints or body surfaces
  Ex: use palm of hand to press the toothpaste to
  toothbrush rather than the fingers
  Use devices – long-handed brushes to brush hair or
  dressing sticks for facilitite wearing of pants

              Maria Carmela L. Domocmat, RN, MSN
Reduction of joint stress
urge to maintain a modest level of activity to
prevent joint laxity and muscular atrophy.
Splinting of acutely inflamed joints, particularly at
night and the use of walking aids (canes, walkers)
are all effective means of reducing stress on
specific joints.




               Maria Carmela L. Domocmat, RN, MSN
Assistive devices




      Computer Keyboard Aid



                                      Arthritic's Pen




 Maria Carmela L. Domocmat, RN, MSN
Phone & Cup Holder with
Hook and Loop Strap




               Maria Carmela L. Domocmat, RN, MSN
Arthritis in your hands
                       causes your finger joints
                       and knuckles to become
                       stiff and sometimes
                       painful and swollen.
                       Protect your hands by
                       avoiding pushing, pulling
                       and twisting motions.
                       Avoid making a tight fist
                       or pinching objects tightly.



Maria Carmela L. Domocmat, RN, MSN
Instead, use a grasp that
                       aligns your knuckles
                       evenly along the handle
                       of the tool or utensil.
                       This makes grasping the
                       tool more comfortable
                       and requires less effort to
                       use the tool.
                       For instance, a built-up
                       handle made of foam can
                       make it easier for you to
                       grasp your toothbrush.

Maria Carmela L. Domocmat, RN, MSN
For tasks that require to pinch
                       objects tightly, look for
                       assistive devices that can help
                       hold the object with less force.
                       special key holder may help
                       turn keys more comfortably
                       without putting strain on hand.
                            This type of holder aligns knuckles
                            evenly along the handle of the tool
                            or utensil, allow use a larger grip
                            to turn the key.




Maria Carmela L. Domocmat, RN, MSN
Use assistive devices to
help you open jars. This
spares your fingers from
the twisting motion
required to open a jar.




                Maria Carmela L. Domocmat, RN, MSN
To protect your finger joints,
avoid tightly pinching with
your fingers.
For example, use a button
aid to help you grasp and
fasten buttons on your
clothes. Choose clothes with
easy-to-close fasteners,
such as zippers, large
buttons or hooks.



                 Maria Carmela L. Domocmat, RN, MSN
Promote balanced diet
Good oral hygiene b4 and after meals
Small, frequent feedings
High-caloric snacks
If with xerostamia – moisten foods, extra fluids with
meals
Eliminate spicy or acidic foods
Sit upright to eat
Take all meds with food and full glass of water – to
ameliorate GI distress
Use assistive device if with stiffness
                Maria Carmela L. Domocmat, RN, MSN
Sjogren‘s syndrome mgmt
Symptomatic treatment
  Artificial tears and saliva
  Lubricants
Moisturizers
Systemic pilocarpine – for dry mouth
Blockade of tear outflow
NSAIDS – for pain




                Maria Carmela L. Domocmat, RN, MSN
Promote decision-making
Exercise healthy control over the disease
  Client should be able to verbalize cause of illness
  Educate the client
Increase participation in decision-making
  allow as many choices as possible
  Decide on own ADL




               Maria Carmela L. Domocmat, RN, MSN
Promote hope
Avoid false reassurance
Help set realistic goals
Praise for accomplishments (no matter how
small)
Active listening
Be sensitive to changes in mind and affect




             Maria Carmela L. Domocmat, RN, MSN
Promote coping
The client would be able to integrate disease
into the demands of daily living
Sign that the client has healthy approach
strategies
  Seek out info and assistance
  Find strength through spiritual support
  Verbalize feelings and concerns
  Set goals
  Express positive thoughts
  Maintain realistic independence

               Maria Carmela L. Domocmat, RN, MSN
Signs of less adaptive strategies
  Avoidance strategies – ex: denial
  Excessive sleeping
  Other passive behaviors
  Depression




              Maria Carmela L. Domocmat, RN, MSN
FATIGUE


          Maria Carmela L. Domocmat, RN, MSN
Management of Fatigue:
For muscle atrophy – aggressive PT to
strengthen muscle and prevent further atrophy




             Maria Carmela L. Domocmat, RN, MSN
Management of Fatigue
Principles of energy conservation
  Pacing activities- do not plan too much activity for one
  day
  Allow rest periods
  Set priorities – determine which activities are most
  important and do them first
  Obtain assistance when needed – delegate
  responsibilities
   balance activity and rest
  Plan ahead to prevent last minute rushing and stress
  Learn own activity tolerance and do not exceed it

               Maria Carmela L. Domocmat, RN, MSN
BODY IMAGE DISTURBANCE


      Maria Carmela L. Domocmat, RN, MSN
Enhance body image
Body image may be affected by both the disease
process and drug therapy
  Ulnar deviation, swan-neck deformity, boutonnière
  deformity, rheumatoid nodules
  Steroid side effect – cushingoid syndrome
Determine client‘s perception of the changes
and impact of reaction of the SO
Most impt Ix – communicate acceptance of the
client ; establish and maintain trusting
relationship to encourage the client to express
feelings
              Maria Carmela L. Domocmat, RN, MSN
Let the client wear own clothes rather than the
hosp gown, brush own hair, use make-up if
desired
Use colored hair accessories , nail polish,
perfume




             Maria Carmela L. Domocmat, RN, MSN
SURGICAL INTERVENTIONS


       Maria Carmela L. Domocmat, RN, MSN
Surgical interventions
Tendon transfer and osteotomy
Synovectomy
Arthrodesis
Joint arthroplasty or replacement




             Maria Carmela L. Domocmat, RN, MSN
Tendon transfer and osteotomy
Nodules or benign bony tumors (exostoses) –
surgically removed and flexion contractures
surgically relieved
Osteotomies
  Excision or cutting through bones




              Maria Carmela L. Domocmat, RN, MSN
Synovectomy
Surgical removal of synovia – elbow, wrist, fingers,
knees




               Maria Carmela L. Domocmat, RN, MSN
Synovectomy
ordinarily not recommended for patients with
rheumatoid arthritis, primarily because relief is
only transient.
synovectomy of the wrist - an exception
  recommended if intense synovitis is persistent despite
  medical treatment over 6 to 12 months.
  Persistent synovitis involving the dorsal compartments
  of the wrist can lead to extensor tendon sheath rupture
  resulting in severe disability of hand function.



                Maria Carmela L. Domocmat, RN, MSN
Synovectomy




Maria Carmela L. Domocmat, RN, MSN
Maria Carmela L. Domocmat, RN, MSN
Arthrodesis
Operation that produce bony fusion of joint
used for clients with bone loss after joint
infection , tumors, musculoskeletal trauma,
paralysis
Immobilize the joint but eliminate some
discomfort or arthritic process
Ankle - most common




             Maria Carmela L. Domocmat, RN, MSN
Joint arthroplasty or replacement
particularly of the knee, hip, wrist, and elbow, are
highly successful.
Arthroplasty of the metacarpophalangeal (knuckle)
joints also can reduce pain and improve function.




               Maria Carmela L. Domocmat, RN, MSN
Hip Replacement




         Maria Carmela L. Domocmat, RN, MSN
Maria Carmela L. Domocmat, RN, MSN
Surgical intervention




   Maria Carmela L. Domocmat, RN, MSN
Surgical intervention
Other operations include
  release of nerve entrapments (e.g., carpal tunnel
  syndrome)
  arthroscopic procedures
  removal of a symptomatic rheumatoid nodule




                Maria Carmela L. Domocmat, RN, MSN
Complementary/ Alternative
          therapies
Pain relief – hypnosis, acupuncture, magnet
Good nutrition
  Omega-3 fatty acids
     Found in coldwater fish (salmon, sea bass, tuna)
     May help reduce inflam
     But amount needed is impractical to human consumption
  Fish oil capsules




                Maria Carmela L. Domocmat, RN, MSN
Complementary/ Alternative
          therapies
Antioxidant vitamins (A,C, E) to help maintain
normal function of the immune system
Trace elements for joint health
  Zinc, Selenium, Copper, Iron




              Maria Carmela L. Domocmat, RN, MSN
Osteoarthritis
associated with the
aging process and
can affect any joint.
The cartilage of the
affected joint is
gradually worn
down, eventually
causing bone to rub
against bone.
Bony spurs develop
on the unprotected
bones, causing pain
and inflammation.
Bouchard‘s nodes
                   Maria Carmela L. Domocmat, RN, MSN
WHAT’S THE DIFFERENCE
BETWEEN RA AND OA?

       Maria Carmela L. Domocmat, RN, MSN
Maria Carmela L. Domocmat, RN, MSN
Osteoarthritis is a deterioration of cartilage and
overgrowth of bone often due to "wear and tear."

Rheumatoid arthritis is the inflammation of a
joint's connective tissues, such as the synovial
membranes, which leads to the destruction of
the joint's cartilage.




              Maria Carmela L. Domocmat, RN, MSN
Known as the ―wear-and-tear‖ kind of arthritis
a chronic condition characterized by the
breakdown of the joint‘s cartilage. Cartilage is the
part of the joint that cushions the ends of the
bones and allows easy movement of joints. The
breakdown of cartilage causes the bones to rub
against each other, causing stiffness, pain and
loss of movement in the joint.



               Maria Carmela L. Domocmat, RN, MSN
AKA
 degenerative joint disease,
 ostoarthrosis,
 hypertrophic arthritis
 degenerative arthritis.




               Maria Carmela L. Domocmat, RN, MSN
stages of osteoarthritis
Cartilage loses elasticity and is more easily
damaged by injury or use.
Wear of cartilage causes changes to underlying
bone. The bone thickens and cysts may occur
under the cartilage. Bony growths, called spurs or
osteophytes, develop near the end of the bone at
the affected joint.




              Maria Carmela L. Domocmat, RN, MSN
stages of osteoarthritis
Bits of bone or cartilage float loosely in the joint
space.
The joint lining, or the synovium, becomes
inflamed due to cartilage breakdown causing
cytokines (inflammation proteins) and enzymes
that damage cartilage further.




                Maria Carmela L. Domocmat, RN, MSN
The main problem in
knee OA is degeneration
of the articular cartilage.
Articular cartilage is the
smooth lining that covers
the ends of bones where
they meet to form the
joint. The cartilage gives
the knee joint freedom of
movement by decreasing
friction.


                 Maria Carmela L. Domocmat, RN, MSN
The articular cartilage is
                      kept slippery by joint fluid
                      made by the joint lining
                      (the synovial membrane).
                      The fluid, called synovial
                      fluid, is contained in a soft
                      tissue enclosure around
                      synovial joints called
                      the joint capsule.




Maria Carmela L. Domocmat, RN, MSN
An important substance
                      present in articular
                      cartilage and synovial
                      fluid is called hyaluronic
                      acid. Hyaluronic acid
                      helps joints collect and
                      hold water, improving
                      lubrication and reducing
                      friction. It also acts by
                      allowing cells to move
                      and work within the joint.


Maria Carmela L. Domocmat, RN, MSN
When the articular
cartilage degenerates, or
wears away, the bone
underneath is uncovered
and rubs against bone.
Small outgrowths called
bone spurs,
or osteophytes, may form
in the joint.




               Maria Carmela L. Domocmat, RN, MSN
Changes in the cartilage and bones of the joint
can lead to pain, stiffness and use limitations.
Deterioration of cartilage can:
  Affect the shape and makeup of the joint so it doesn‘t
  function smoothly. - limp when walk or have trouble
  going up and down stairs.
  Cause fragments of bone and cartilage to float in joint fluid
  causing irritation and pain.
  Cause bony spurs, called osteophytes, to develop near
  the ends of bones
  Mean the joint fluid doesn‘t have enough hyaluronan,
  which affects the joint‘s ability to absorb shock.
                 Maria Carmela L. Domocmat, RN, MSN
Maria Carmela L. Domocmat, RN, MSN
Causes and Risk factors
there is no single known cause of osteoarthritis
(OA),
there are several risk factors that should be
considered
  Age
  Obesity
  Injury or Overuse
  Genetics or Heredity
  Muscle Weakness
  Other Diseases and Types of Arthritis

               Maria Carmela L. Domocmat, RN, MSN
Maria Carmela L. Domocmat, RN, MSN
Treatment
Acetaminophen
Nonsteroidal anti-inflammatory drugs (NSAIDs) or
COX-2 medications
Capsaicin
Tramadol
Narcotic pain relievers
glucosamine sulfate and chondroitin sulfate



              Maria Carmela L. Domocmat, RN, MSN
Acetaminophen
 Tylenol, Anacin-3, Panadal, Phenaphen,
Valadol, and others)
for mild to moderate osteoarthritis.
usually the first choice




             Maria Carmela L. Domocmat, RN, MSN
Nonsteroidal anti-inflammatory
       drugs (NSAIDs)
for moderate to severe arthritic pain.
OTC NSAIDs
Prescription NSAIDs include




              Maria Carmela L. Domocmat, RN, MSN
Drugs for Prevention NSAID-
         Induced Ulcers
If NSAID-induced ulcers are identified switch to
alternative pain relievers.




             Maria Carmela L. Domocmat, RN, MSN
Topical NSAIDs




           $63.07
 Maria Carmela L. Domocmat, RN, MSN
Capsaicin (Zostrix)
is an ointment prepared from the active
ingredient in hot chili peppers that has been
helpful for relieving painful areas in other
disorders.




              Maria Carmela L. Domocmat, RN, MSN
SALONPAS PAIN PATCH WITH CAPSAICIN




          Maria Carmela L. Domocmat, RN, MSN
Tramadol (Ultram)
is a pain reliever that has some properties that
are similar to narcotics.
not as addictive, however, and may be an
alternative for patients who do not respond to
NSAIDs or less potent agents.




              Maria Carmela L. Domocmat, RN, MSN
Maria Carmela L. Domocmat, RN, MSN
Narcotic pain relievers
oxycodone, oxymorphone, or morphine
may be necessary for severe pain that does not
respond to less potent pain relievers.




             Maria Carmela L. Domocmat, RN, MSN
http://differncebetween.infoloommedia.netdna-cdn.com/wp-
content/uploads/2009/11/oxycodone.png
                                                           Maria Carmela L. Domocmat, RN, MSN
Management
Same with RA




           Maria Carmela L. Domocmat, RN, MSN
Let‘s Exercise
http://www.medicinenet.com/rheumatoid_arthritis
_exercises_slideshow/article.htm




             Maria Carmela L. Domocmat, RN, MSN
Maria Carmela L. Domocmat, RN, MSN
Gouty arthritis
is a disease characterized by an abnormal
metabolism of uric acid, resulting in an excess of
uric acid in the tissues and blood causing
inflammation
People with gout either produce too much uric
acid, or more commonly, their bodies have a
problem in removing it.
AKA
   gout
   the disease of kings
  the king of diseases
               Maria Carmela L. Domocmat, RN, MSN
Gouty arthritis
2 major types
  Primary
  Secondary




                Maria Carmela L. Domocmat, RN, MSN
Gouty arthritis
Primary
  Inherited X-lined trait
  Caused by several inborn errors of purine metabolism
    Uric acid- is the end-product of purine metabolism; excreted
    in urine
  Production of uric acid exceeds the excretion
  capability of kidneys
  Sodium urate is deposited in the synovium and other
  tissues which results in inflammation
  Males, 30‘s and 40‘s


                Maria Carmela L. Domocmat, RN, MSN
Gouty arthritis
Secondary
  Hyperuricemia
     Excessive uric acid in blood casued by anoterh disease
  Affects all ages
     Renal insufficiency
     Diuretic therapy
     Multiple myeloma
     Carcinomas
  Causes:
     decreased normal excretion of uric acid and other waste
     products
     Increased production of uric acid
                 Maria Carmela L. Domocmat, RN, MSN
Four Stages Of Gouty Arthritis
Asymptomatic Hyperuricemia

Acute Gout / Acute Gouty Arthritis

Interval / Intercritical

Chronic Tophaceous Gout




              Maria Carmela L. Domocmat, RN, MSN
Four Stages Of Gouty Arthritis
Asymptomatic Hyperuricemia:
  Asypmptomatic but with elevated blood uric acid
  levels

 Serum uric acid level (mg/dl) Incidence of gout

 >9.0                          7.0-8.9

 7.0-8.9                       0.5-0.37

 <7.0                          0.1%




                   Maria Carmela L. Domocmat, RN, MSN
Four Stages Of Gouty Arthritis
Acute Gout / Acute Gouty Arthritis
  hyperuricemia has caused deposits of uric acid
  crystals in joint spaces, leading to gouty attacks.
  Excruciating pain and inflammation of one or more
  joints – esp metatarsophalangeal joints of the great
  toe (podagra)
  Increased ESR, WBC




               Maria Carmela L. Domocmat, RN, MSN
Maria Carmela L. Domocmat, RN, MSN
http://cdn.nursingcrib.com/wp-content/uploads/gouty-arthritis.jpg



                                   Maria Carmela L. Domocmat, RN, MSN
http://img.medscape.com/slide/migrated/e
ditorial/cmecircle/2004/3689/images/cohen
/slide019.gif




                                        Maria Carmela L. Domocmat, RN, MSN
Four Stages Of Gouty Arthritis
Interval / Intercritical
  the periods between acute gouty attacks – may be
  months or years after the 1st attack
  Asymptomatic period
  No abnormality in joints


Chronic Tophaceous Gout:
  the disease has caused permanent damage
  Deposits or urate crytals under skin and within major
  organs (i.e., urate kidney stone formation)

               Maria Carmela L. Domocmat, RN, MSN
Tophi
        Tophi – deposits of sodium urate crystals
               May occur anywhere; common in outer ear




http://www.hopkins-arthritis.org/images/gout_fig7.gif


                                         Maria Carmela L. Domocmat, RN, MSN
http://www.cdaarthritis.com/images_slides/40_gout_b_toe1_360.jpg




        Maria Carmela L. Domocmat, RN, MSN
http://img.medsca
pe.com/slide/migr
ated/editorial/cme
circle/2004/3689/i
mages/cohen/slid
e019.gif




                     Maria Carmela L. Domocmat, RN, MSN
http://img.medscape.com/slide/migr
                                     ated/editorial/cmecircle/2004/3689/i
                                     mages/cohen/slide019.gif




Maria Carmela L. Domocmat, RN, MSN
http://msnbcmedia1.msn.com/i/ms
                                     nbc/Components/Interactives/Healt
                                     h/MiscHealth/GOUT.gif




Maria Carmela L. Domocmat, RN, MSN
http://img.medscape.com/slide/migrated/editorial/cmecircle/2004/3689/images/cohen/slide019.gif



            Maria Carmela L. Domocmat, RN, MSN
Dx tests
Synovial fluid analysis (shows uric acid crystals)
Uric acid - blood
Joint x-rays (may be normal)
Synovial biopsy
Uric acid - urine




              Maria Carmela L. Domocmat, RN, MSN
Maria Carmela L. Domocmat, RN, MSN
Management
Drug therapy
Diet therapy




               Maria Carmela L. Domocmat, RN, MSN
Management
Drug therapy
  acute gouty arthritis – inflammation subsides
  spontaneously within 3 to 5 days
  But if cannot tolerate pain
    Colchicine (Colsalide, Novocolchicine) and NSAIDs
    Taken for 4-7 days
  (NSAIDs) -Indomethacin (Indocin), ibuprofen (Advil),
  and naproxen (Aleve), celecoxib (Celebrex)
  painkillers such as codeine, hydrocodone,
  and oxycodone
  Corticosteroids

               Maria Carmela L. Domocmat, RN, MSN
Management
Drug therapy
  Chronic or repeated acute episodes
     Allopurinol (Zyloprim)
        A xanthine oxidase inhibitor – prevents conversion of xanthine
        to uric acid
    Probenecid (Benemid, Benuryl)
        Uricosuric drug – promotes excretion of excess uric acid
        drink at least 2 liters of fluid a day while taking this medication
        (to help prevent uric acid kidney stones from forming).
    Combination drug
        Probenecid and Colchicine (ColBenemid)
  Note: avoid aspirin – it inactivates the drug

                 Maria Carmela L. Domocmat, RN, MSN
Maria Carmela L. Domocmat, RN, MSN
Febuxostat (Uloric)
               first new medication developed specifically for the
               control of gout in over 40 years.
               Decreases formation of uric acid by the body and is a
               very reliable way to lower the blood uric acid level.
               can be used in patients with mild to moderate kidney
               impairment.
               should not be taken with 6-mercaptopurine (6-MP), or
               azathioprine.

http://www.emedicinehealth.com/gout/page7_em.htm#Medications



                                      Maria Carmela L. Domocmat, RN, MSN
Maria Carmela L. Domocmat, RN, MSN
Management
        Diet therapy
               Avoid alcohol, anchovies, sardines, oils, herring,
              organ meat (liver, kidney, and sweetbreads), legumes
              (dried beans and peas), gravies, mushrooms,
              spinach, asparagus, cauliflower, consommé, and
              baking or brewer's yeast.




http://www.ncbi.nlm.nih.gov/pubmedhealth/PMH0001459/



                                     Maria Carmela L. Domocmat, RN, MSN
Limit meat
        Avoid fatty foods such as salad dressings, ice
        cream, and fried foods.
        Eat enough carbohydrates.
        If losing weight, lose it slowly. Quick weight loss
        may cause uric acid kidney stones to form.



http://www.ncbi.nlm.nih.gov/pubmedhealth/PMH0001459/



                                     Maria Carmela L. Domocmat, RN, MSN
http://s1.hubimg.com/u/1184832_f496.jpg
                                          Maria Carmela L. Domocmat, RN, MSN
Avoid all forms of aspirin and diuretics – may
precipitate attack
Excessive physical or emotional stress- can
exacerbate disease




             Maria Carmela L. Domocmat, RN, MSN
Prevention of kidney stone
            formation
Increase fluid intake – prevent stone formation
  Dilute urine and prevent sediment formation
Alkaline ash diet
  Citrus fruits, juices, milk and certain dairy products
  Uric acid is more soluble in high pH urine – less likely
  to form urinary stones




               Maria Carmela L. Domocmat, RN, MSN
Complications
Chronic gouty arthritis
Kidney stones
Deposits in the kidneys, leading to chronic
kidney failure




             Maria Carmela L. Domocmat, RN, MSN

Más contenido relacionado

La actualidad más candente

La actualidad más candente (20)

Polyarteritis nodosa
Polyarteritis nodosaPolyarteritis nodosa
Polyarteritis nodosa
 
Dermatomyositis
DermatomyositisDermatomyositis
Dermatomyositis
 
Rheumatoid arthritis
Rheumatoid arthritisRheumatoid arthritis
Rheumatoid arthritis
 
Rhematoid arthiritis
Rhematoid arthiritisRhematoid arthiritis
Rhematoid arthiritis
 
Vasculitis
VasculitisVasculitis
Vasculitis
 
Reactive Arthritis
Reactive  ArthritisReactive  Arthritis
Reactive Arthritis
 
Seronegative spondyloarthropathies
Seronegative spondyloarthropathiesSeronegative spondyloarthropathies
Seronegative spondyloarthropathies
 
Approach to the patient with arthritis
Approach to the patient with arthritisApproach to the patient with arthritis
Approach to the patient with arthritis
 
Systemic Lupus Erythematosus
Systemic Lupus ErythematosusSystemic Lupus Erythematosus
Systemic Lupus Erythematosus
 
Sle ppt
Sle pptSle ppt
Sle ppt
 
Polyarthritis (clinical approach)
Polyarthritis (clinical approach)Polyarthritis (clinical approach)
Polyarthritis (clinical approach)
 
SYSTEMIC LUPUS ERYTHEMATOSUS (SLE
SYSTEMIC LUPUS ERYTHEMATOSUS (SLESYSTEMIC LUPUS ERYTHEMATOSUS (SLE
SYSTEMIC LUPUS ERYTHEMATOSUS (SLE
 
SLE
SLESLE
SLE
 
Rheumatoid arthritis
Rheumatoid arthritis Rheumatoid arthritis
Rheumatoid arthritis
 
Scleroderma
SclerodermaScleroderma
Scleroderma
 
Rheumatoid Arthritis
Rheumatoid ArthritisRheumatoid Arthritis
Rheumatoid Arthritis
 
Rheumatoid arthritis
Rheumatoid arthritisRheumatoid arthritis
Rheumatoid arthritis
 
Arthritis
ArthritisArthritis
Arthritis
 
Connective tissue diseases (7)
Connective tissue diseases (7)Connective tissue diseases (7)
Connective tissue diseases (7)
 
ARTHRITIS & RHEUMATOLOGY by DR K. DELE
ARTHRITIS & RHEUMATOLOGY by DR K. DELEARTHRITIS & RHEUMATOLOGY by DR K. DELE
ARTHRITIS & RHEUMATOLOGY by DR K. DELE
 

Destacado

Rheumatic Disorders Part II
Rheumatic Disorders Part IIRheumatic Disorders Part II
Rheumatic Disorders Part IICarmela Domocmat
 
Rheumatic Disorders Part III
Rheumatic Disorders Part IIIRheumatic Disorders Part III
Rheumatic Disorders Part IIICarmela Domocmat
 
Rheumatic Disorders Part IV
Rheumatic Disorders Part IVRheumatic Disorders Part IV
Rheumatic Disorders Part IVCarmela Domocmat
 
الأمراض الروماتزمية
الأمراض الروماتزميةالأمراض الروماتزمية
الأمراض الروماتزميةsnouzika
 
Rheumatology pearls 9-19-2014
Rheumatology pearls 9-19-2014Rheumatology pearls 9-19-2014
Rheumatology pearls 9-19-2014Paul Sufka
 
Clinical approch to rheumatological examination
Clinical approch to rheumatological examinationClinical approch to rheumatological examination
Clinical approch to rheumatological examinationAshraf Okba
 
Hypersensitivity reactions
Hypersensitivity  reactions Hypersensitivity  reactions
Hypersensitivity reactions Carmela Domocmat
 
Connective Tissue Diseases
Connective Tissue DiseasesConnective Tissue Diseases
Connective Tissue Diseaseskatejohnpunag
 
7 13 Connective Tissue Disease
7 13 Connective Tissue Disease7 13 Connective Tissue Disease
7 13 Connective Tissue DiseaseMiami Dade
 
Bone and joint infections: Osteomyelitis, Septic Arthritis
Bone and joint infections: Osteomyelitis, Septic ArthritisBone and joint infections: Osteomyelitis, Septic Arthritis
Bone and joint infections: Osteomyelitis, Septic ArthritisCarmela Domocmat
 
Rheumatic disorders summary
Rheumatic disorders summaryRheumatic disorders summary
Rheumatic disorders summaryRasha Dabbagh
 
Treatment of recurrent and resistant dermatomyositis and polymyositis in adults
Treatment of recurrent and resistant dermatomyositis and polymyositis in adultsTreatment of recurrent and resistant dermatomyositis and polymyositis in adults
Treatment of recurrent and resistant dermatomyositis and polymyositis in adultsMansoura university Hospital
 
IAS_NetworkNewsletter
IAS_NetworkNewsletterIAS_NetworkNewsletter
IAS_NetworkNewsletterMaggie Pajak
 

Destacado (20)

Rheumatic Disorders Part II
Rheumatic Disorders Part IIRheumatic Disorders Part II
Rheumatic Disorders Part II
 
Rheumatic Disorders Part III
Rheumatic Disorders Part IIIRheumatic Disorders Part III
Rheumatic Disorders Part III
 
Rheumatic Disorders Part IV
Rheumatic Disorders Part IVRheumatic Disorders Part IV
Rheumatic Disorders Part IV
 
Rheumatology Sheet
Rheumatology SheetRheumatology Sheet
Rheumatology Sheet
 
الأمراض الروماتزمية
الأمراض الروماتزميةالأمراض الروماتزمية
الأمراض الروماتزمية
 
Rheumatology pearls 9-19-2014
Rheumatology pearls 9-19-2014Rheumatology pearls 9-19-2014
Rheumatology pearls 9-19-2014
 
Rheumatology 2
Rheumatology 2Rheumatology 2
Rheumatology 2
 
Signs and symptoms in rheumatology
Signs and symptoms in rheumatologySigns and symptoms in rheumatology
Signs and symptoms in rheumatology
 
Clinical approch to rheumatological examination
Clinical approch to rheumatological examinationClinical approch to rheumatological examination
Clinical approch to rheumatological examination
 
Rheumatology sheet
Rheumatology sheetRheumatology sheet
Rheumatology sheet
 
Hypersensitivity reactions
Hypersensitivity  reactions Hypersensitivity  reactions
Hypersensitivity reactions
 
Connective Tissue Diseases
Connective Tissue DiseasesConnective Tissue Diseases
Connective Tissue Diseases
 
7 13 Connective Tissue Disease
7 13 Connective Tissue Disease7 13 Connective Tissue Disease
7 13 Connective Tissue Disease
 
Bone and joint infections: Osteomyelitis, Septic Arthritis
Bone and joint infections: Osteomyelitis, Septic ArthritisBone and joint infections: Osteomyelitis, Septic Arthritis
Bone and joint infections: Osteomyelitis, Septic Arthritis
 
Rheumatic Heart Disease
Rheumatic Heart DiseaseRheumatic Heart Disease
Rheumatic Heart Disease
 
Rheumatic disorders summary
Rheumatic disorders summaryRheumatic disorders summary
Rheumatic disorders summary
 
Treatment of recurrent and resistant dermatomyositis and polymyositis in adults
Treatment of recurrent and resistant dermatomyositis and polymyositis in adultsTreatment of recurrent and resistant dermatomyositis and polymyositis in adults
Treatment of recurrent and resistant dermatomyositis and polymyositis in adults
 
Emphisema
EmphisemaEmphisema
Emphisema
 
Choice of TNF b. for extra-articular manifestations in SpA
Choice of TNF b. for extra-articular manifestations in SpAChoice of TNF b. for extra-articular manifestations in SpA
Choice of TNF b. for extra-articular manifestations in SpA
 
IAS_NetworkNewsletter
IAS_NetworkNewsletterIAS_NetworkNewsletter
IAS_NetworkNewsletter
 

Similar a Rheumatic Disorders Part I

Autoimmune disorders.RA, OA, Gout
Autoimmune disorders.RA, OA, Gout Autoimmune disorders.RA, OA, Gout
Autoimmune disorders.RA, OA, Gout Carmela Domocmat
 
Autoimmune disorders Part II
Autoimmune disorders Part IIAutoimmune disorders Part II
Autoimmune disorders Part IICarmela Domocmat
 
Polymyositis Dermatomyositis
Polymyositis DermatomyositisPolymyositis Dermatomyositis
Polymyositis DermatomyositisZia ul Haq Nawaz
 
Differential diagnosis of musculoskeletal involvement in rheumatoid arthritis...
Differential diagnosis of musculoskeletal involvement in rheumatoid arthritis...Differential diagnosis of musculoskeletal involvement in rheumatoid arthritis...
Differential diagnosis of musculoskeletal involvement in rheumatoid arthritis...abdelrazekdawod
 
Idiopathic inflammatory myopathy
Idiopathic inflammatory myopathyIdiopathic inflammatory myopathy
Idiopathic inflammatory myopathydattasrisaila
 
Pharmacotherapy of Rheumatoid arthritis
Pharmacotherapy of Rheumatoid arthritisPharmacotherapy of Rheumatoid arthritis
Pharmacotherapy of Rheumatoid arthritisKoppala RVS Chaitanya
 
Approach to muscle disorders
Approach to muscle disordersApproach to muscle disorders
Approach to muscle disordersLobna A.Mohamed
 
idiopathic Inflammatory myositis
idiopathic Inflammatory myositis idiopathic Inflammatory myositis
idiopathic Inflammatory myositis Amar Patil
 
SEMINAR PRESENTATION ON RHEUMATOID ARTHRITIS.pptx
SEMINAR PRESENTATION ON RHEUMATOID ARTHRITIS.pptxSEMINAR PRESENTATION ON RHEUMATOID ARTHRITIS.pptx
SEMINAR PRESENTATION ON RHEUMATOID ARTHRITIS.pptxmrcopyxerox
 
Diabetic Foot and Ulcer​.pptx
Diabetic Foot and Ulcer​.pptxDiabetic Foot and Ulcer​.pptx
Diabetic Foot and Ulcer​.pptxssuser3a10ef
 
Spinal Cord Disease - Clinical Presentations and Management
Spinal Cord Disease - Clinical Presentations and ManagementSpinal Cord Disease - Clinical Presentations and Management
Spinal Cord Disease - Clinical Presentations and ManagementJoseph Paul, MD
 
Pathophysiology of Rheumatoid Arthritis
Pathophysiology of  Rheumatoid ArthritisPathophysiology of  Rheumatoid Arthritis
Pathophysiology of Rheumatoid ArthritisNem kumar Jain
 
Skeletal muscles disease and disorder
Skeletal muscles disease and disorderSkeletal muscles disease and disorder
Skeletal muscles disease and disorderDiNa Amin
 
Joint syndrome differential diagnosis between scleroderma , dermatomyositis n...
Joint syndrome differential diagnosis between scleroderma , dermatomyositis n...Joint syndrome differential diagnosis between scleroderma , dermatomyositis n...
Joint syndrome differential diagnosis between scleroderma , dermatomyositis n...Daniel David
 
RHEUMATOID ARTHRITIS BY DR BASHIR AHMED DAR ASSOCIATE PROFESSOR MEDICINE SOPO...
RHEUMATOID ARTHRITIS BY DR BASHIR AHMED DAR ASSOCIATE PROFESSOR MEDICINE SOPO...RHEUMATOID ARTHRITIS BY DR BASHIR AHMED DAR ASSOCIATE PROFESSOR MEDICINE SOPO...
RHEUMATOID ARTHRITIS BY DR BASHIR AHMED DAR ASSOCIATE PROFESSOR MEDICINE SOPO...Prof Dr Bashir Ahmed Dar
 
TREATMENT OF RHEUMATOID ARTHRITIS BY DR BASHIR AHMED DAR ASSOCIATE PROFESSOR ...
TREATMENT OF RHEUMATOID ARTHRITIS BY DR BASHIR AHMED DAR ASSOCIATE PROFESSOR ...TREATMENT OF RHEUMATOID ARTHRITIS BY DR BASHIR AHMED DAR ASSOCIATE PROFESSOR ...
TREATMENT OF RHEUMATOID ARTHRITIS BY DR BASHIR AHMED DAR ASSOCIATE PROFESSOR ...Prof Dr Bashir Ahmed Dar
 

Similar a Rheumatic Disorders Part I (20)

Autoimmune disorders.RA, OA, Gout
Autoimmune disorders.RA, OA, Gout Autoimmune disorders.RA, OA, Gout
Autoimmune disorders.RA, OA, Gout
 
Autoimmune disorders Part II
Autoimmune disorders Part IIAutoimmune disorders Part II
Autoimmune disorders Part II
 
Polymyositis Dermatomyositis
Polymyositis DermatomyositisPolymyositis Dermatomyositis
Polymyositis Dermatomyositis
 
Differential diagnosis of musculoskeletal involvement in rheumatoid arthritis...
Differential diagnosis of musculoskeletal involvement in rheumatoid arthritis...Differential diagnosis of musculoskeletal involvement in rheumatoid arthritis...
Differential diagnosis of musculoskeletal involvement in rheumatoid arthritis...
 
Topic of the month...Transverse myelitis
Topic of the month...Transverse myelitisTopic of the month...Transverse myelitis
Topic of the month...Transverse myelitis
 
Idiopathic inflammatory myopathy
Idiopathic inflammatory myopathyIdiopathic inflammatory myopathy
Idiopathic inflammatory myopathy
 
Pharmacotherapy of Rheumatoid arthritis
Pharmacotherapy of Rheumatoid arthritisPharmacotherapy of Rheumatoid arthritis
Pharmacotherapy of Rheumatoid arthritis
 
Approach to muscle disorders
Approach to muscle disordersApproach to muscle disorders
Approach to muscle disorders
 
idiopathic Inflammatory myositis
idiopathic Inflammatory myositis idiopathic Inflammatory myositis
idiopathic Inflammatory myositis
 
SEMINAR PRESENTATION ON RHEUMATOID ARTHRITIS.pptx
SEMINAR PRESENTATION ON RHEUMATOID ARTHRITIS.pptxSEMINAR PRESENTATION ON RHEUMATOID ARTHRITIS.pptx
SEMINAR PRESENTATION ON RHEUMATOID ARTHRITIS.pptx
 
Transverse myelitis
Transverse myelitisTransverse myelitis
Transverse myelitis
 
Diabetic Foot and Ulcer​.pptx
Diabetic Foot and Ulcer​.pptxDiabetic Foot and Ulcer​.pptx
Diabetic Foot and Ulcer​.pptx
 
Spinal Cord Disease - Clinical Presentations and Management
Spinal Cord Disease - Clinical Presentations and ManagementSpinal Cord Disease - Clinical Presentations and Management
Spinal Cord Disease - Clinical Presentations and Management
 
Dermatomyositis
DermatomyositisDermatomyositis
Dermatomyositis
 
Pathophysiology of Rheumatoid Arthritis
Pathophysiology of  Rheumatoid ArthritisPathophysiology of  Rheumatoid Arthritis
Pathophysiology of Rheumatoid Arthritis
 
Ra
RaRa
Ra
 
Skeletal muscles disease and disorder
Skeletal muscles disease and disorderSkeletal muscles disease and disorder
Skeletal muscles disease and disorder
 
Joint syndrome differential diagnosis between scleroderma , dermatomyositis n...
Joint syndrome differential diagnosis between scleroderma , dermatomyositis n...Joint syndrome differential diagnosis between scleroderma , dermatomyositis n...
Joint syndrome differential diagnosis between scleroderma , dermatomyositis n...
 
RHEUMATOID ARTHRITIS BY DR BASHIR AHMED DAR ASSOCIATE PROFESSOR MEDICINE SOPO...
RHEUMATOID ARTHRITIS BY DR BASHIR AHMED DAR ASSOCIATE PROFESSOR MEDICINE SOPO...RHEUMATOID ARTHRITIS BY DR BASHIR AHMED DAR ASSOCIATE PROFESSOR MEDICINE SOPO...
RHEUMATOID ARTHRITIS BY DR BASHIR AHMED DAR ASSOCIATE PROFESSOR MEDICINE SOPO...
 
TREATMENT OF RHEUMATOID ARTHRITIS BY DR BASHIR AHMED DAR ASSOCIATE PROFESSOR ...
TREATMENT OF RHEUMATOID ARTHRITIS BY DR BASHIR AHMED DAR ASSOCIATE PROFESSOR ...TREATMENT OF RHEUMATOID ARTHRITIS BY DR BASHIR AHMED DAR ASSOCIATE PROFESSOR ...
TREATMENT OF RHEUMATOID ARTHRITIS BY DR BASHIR AHMED DAR ASSOCIATE PROFESSOR ...
 

Más de Carmela Domocmat

Nursing Process and Critical Thinking
Nursing Process and Critical ThinkingNursing Process and Critical Thinking
Nursing Process and Critical ThinkingCarmela Domocmat
 
Assessment peripheral blood vessel
Assessment peripheral blood vessel Assessment peripheral blood vessel
Assessment peripheral blood vessel Carmela Domocmat
 
Assessments heart & neck vessel
Assessments heart  & neck vessel Assessments heart  & neck vessel
Assessments heart & neck vessel Carmela Domocmat
 
Formulating hypothesis in nursing research
Formulating hypothesis in nursing research Formulating hypothesis in nursing research
Formulating hypothesis in nursing research Carmela Domocmat
 
Nursing Care of Clients with Stroke
Nursing Care of Clients with StrokeNursing Care of Clients with Stroke
Nursing Care of Clients with StrokeCarmela Domocmat
 
University of the Philippines Manila - National Institutes of Health (UPM-NIH...
University of the Philippines Manila - National Institutes of Health (UPM-NIH...University of the Philippines Manila - National Institutes of Health (UPM-NIH...
University of the Philippines Manila - National Institutes of Health (UPM-NIH...Carmela Domocmat
 
Statistical Research and Training Center 2013 Training Seminar Schedule
Statistical Research and Training Center 2013 Training Seminar ScheduleStatistical Research and Training Center 2013 Training Seminar Schedule
Statistical Research and Training Center 2013 Training Seminar ScheduleCarmela Domocmat
 
Fluid & electrolytes cld part 1
Fluid & electrolytes cld part 1Fluid & electrolytes cld part 1
Fluid & electrolytes cld part 1Carmela Domocmat
 
Complications of Diabetes Mellitus
Complications of Diabetes MellitusComplications of Diabetes Mellitus
Complications of Diabetes MellitusCarmela Domocmat
 
Management of Diabetes Mellitus
Management of Diabetes MellitusManagement of Diabetes Mellitus
Management of Diabetes MellitusCarmela Domocmat
 
Nursing Care of Clients with Hematologic Problems Part 1 of 2
Nursing Care of Clients with Hematologic Problems Part 1 of 2 Nursing Care of Clients with Hematologic Problems Part 1 of 2
Nursing Care of Clients with Hematologic Problems Part 1 of 2 Carmela Domocmat
 
Nursing Care of Clients with Hematologic Problems Part 2 of 2 : Thrombocytes ...
Nursing Care of Clients with Hematologic Problems Part 2 of 2 : Thrombocytes ...Nursing Care of Clients with Hematologic Problems Part 2 of 2 : Thrombocytes ...
Nursing Care of Clients with Hematologic Problems Part 2 of 2 : Thrombocytes ...Carmela Domocmat
 
Nursing Care of Clients with Hypertension
Nursing Care of Clients with HypertensionNursing Care of Clients with Hypertension
Nursing Care of Clients with HypertensionCarmela Domocmat
 
Nursing Care of Clients with Peripheral Vascular Disorders Part 3 of 3
Nursing Care of Clients with Peripheral Vascular Disorders Part 3 of 3 Nursing Care of Clients with Peripheral Vascular Disorders Part 3 of 3
Nursing Care of Clients with Peripheral Vascular Disorders Part 3 of 3 Carmela Domocmat
 
Nursing Care of Clients with Peripheral Vascular Disorders Part 2 of 3
Nursing Care of Clients with Peripheral Vascular Disorders Part 2 of 3  Nursing Care of Clients with Peripheral Vascular Disorders Part 2 of 3
Nursing Care of Clients with Peripheral Vascular Disorders Part 2 of 3 Carmela Domocmat
 
Nursing Care of Clients with Peripheral Vascular Disorders Part 1 of 3
Nursing Care of Clients with Peripheral Vascular Disorders Part 1 of 3 Nursing Care of Clients with Peripheral Vascular Disorders Part 1 of 3
Nursing Care of Clients with Peripheral Vascular Disorders Part 1 of 3 Carmela Domocmat
 

Más de Carmela Domocmat (20)

Nursing Process and Critical Thinking
Nursing Process and Critical ThinkingNursing Process and Critical Thinking
Nursing Process and Critical Thinking
 
The Client in Context
The Client in ContextThe Client in Context
The Client in Context
 
Assessment peripheral blood vessel
Assessment peripheral blood vessel Assessment peripheral blood vessel
Assessment peripheral blood vessel
 
Assessments heart & neck vessel
Assessments heart  & neck vessel Assessments heart  & neck vessel
Assessments heart & neck vessel
 
Formulating hypothesis in nursing research
Formulating hypothesis in nursing research Formulating hypothesis in nursing research
Formulating hypothesis in nursing research
 
Nursing Care of Clients with Stroke
Nursing Care of Clients with StrokeNursing Care of Clients with Stroke
Nursing Care of Clients with Stroke
 
University of the Philippines Manila - National Institutes of Health (UPM-NIH...
University of the Philippines Manila - National Institutes of Health (UPM-NIH...University of the Philippines Manila - National Institutes of Health (UPM-NIH...
University of the Philippines Manila - National Institutes of Health (UPM-NIH...
 
Statistical Research and Training Center 2013 Training Seminar Schedule
Statistical Research and Training Center 2013 Training Seminar ScheduleStatistical Research and Training Center 2013 Training Seminar Schedule
Statistical Research and Training Center 2013 Training Seminar Schedule
 
Fluid & electrolytes cld part 1
Fluid & electrolytes cld part 1Fluid & electrolytes cld part 1
Fluid & electrolytes cld part 1
 
Parenteral fluid therapy
Parenteral fluid therapyParenteral fluid therapy
Parenteral fluid therapy
 
Immune system
Immune systemImmune system
Immune system
 
Complications of Diabetes Mellitus
Complications of Diabetes MellitusComplications of Diabetes Mellitus
Complications of Diabetes Mellitus
 
Management of Diabetes Mellitus
Management of Diabetes MellitusManagement of Diabetes Mellitus
Management of Diabetes Mellitus
 
Diabetes mellitus
Diabetes mellitusDiabetes mellitus
Diabetes mellitus
 
Nursing Care of Clients with Hematologic Problems Part 1 of 2
Nursing Care of Clients with Hematologic Problems Part 1 of 2 Nursing Care of Clients with Hematologic Problems Part 1 of 2
Nursing Care of Clients with Hematologic Problems Part 1 of 2
 
Nursing Care of Clients with Hematologic Problems Part 2 of 2 : Thrombocytes ...
Nursing Care of Clients with Hematologic Problems Part 2 of 2 : Thrombocytes ...Nursing Care of Clients with Hematologic Problems Part 2 of 2 : Thrombocytes ...
Nursing Care of Clients with Hematologic Problems Part 2 of 2 : Thrombocytes ...
 
Nursing Care of Clients with Hypertension
Nursing Care of Clients with HypertensionNursing Care of Clients with Hypertension
Nursing Care of Clients with Hypertension
 
Nursing Care of Clients with Peripheral Vascular Disorders Part 3 of 3
Nursing Care of Clients with Peripheral Vascular Disorders Part 3 of 3 Nursing Care of Clients with Peripheral Vascular Disorders Part 3 of 3
Nursing Care of Clients with Peripheral Vascular Disorders Part 3 of 3
 
Nursing Care of Clients with Peripheral Vascular Disorders Part 2 of 3
Nursing Care of Clients with Peripheral Vascular Disorders Part 2 of 3  Nursing Care of Clients with Peripheral Vascular Disorders Part 2 of 3
Nursing Care of Clients with Peripheral Vascular Disorders Part 2 of 3
 
Nursing Care of Clients with Peripheral Vascular Disorders Part 1 of 3
Nursing Care of Clients with Peripheral Vascular Disorders Part 1 of 3 Nursing Care of Clients with Peripheral Vascular Disorders Part 1 of 3
Nursing Care of Clients with Peripheral Vascular Disorders Part 1 of 3
 

Rheumatic Disorders Part I

  • 1. Autoimmune Disorders Part I: Rheumatoid Arthritis, Osteoarthritis, & Gouty Arthritis Maria Carmela L. Domocmat, RN, MSN Instructor, School of Nursing Northern Luzon Adventist College
  • 2. IMMUNE TOLERANCE: ability to recognize or distinguish self (self- antigens) from non-self (foreign antigens) like bacteria or viruses. immune system is tolerant to the host‘s tissues but is able to reject foreign tissues and destroy infectious agents.
  • 3. Autoimmune Disorders failure of the tolerance mechanism immune reaction against self-antigens usually occurs after destruction of some of the body‘s tissues  release of ‗self antigens‘ that circulate in the body  acquired immunity (activated T cells or antibodies) Maria Carmela L. Domocmat, RN, MSN
  • 4. Why does the immune system attack the body that it‘s supposed to protect? Failure to recognize some cells as ―self‖ in rheumatic fever, the streptococcus antigen is very similar to a protein in heart tissue, so the body mistakenly identifies heart tissues as foreign When the immune system sees ―self‖ antigens as ―nonself‖ cells seen as foreign are attacked and destroyed may be only a few select cells or organs (organ-specific) – e.g., multiple sclerosis, juvenile diabetes, rheumatic fever may be systemic - e.g., systemic lupus erythematosus, rheumatoid arthritis Maria Carmela L. Domocmat, RN, MSN
  • 5. Autoimmune Disorders Incidence ~ 3.5 % of people have autoimmune diseases On average, women are 2.7 times more likely to develop these diseases than men Maria Carmela L. Domocmat, RN, MSN
  • 6. Autoimmune Disorders Cause: most have no known cause may be due to genetic factors, infectious agents, gender, and age Effect: The autoimmune response results in tissue damage Some damage occurs in only one or a few organs, in other cases it may be body-wide (systemic) Maria Carmela L. Domocmat, RN, MSN
  • 7. Autoimmune Disorders Treatment No Cure Symptomatic treatment Maria Carmela L. Domocmat, RN, MSN
  • 8. CONNECTIVE TISSUE: A REVIEW Maria Carmela L. Domocmat, RN, MSN
  • 9. Connective tissue is a type of tissue made up of fibers forming a framework and support structure for body tissues and organs. Maria Carmela L. Domocmat, RN, MSN
  • 10. Connective tissue is the material between the cells of the body that gives tissues form and strength. This "cellular glue" is also involved in delivering nutrients to the tissue, and in the special functioning of certain tissues. surrounds many organs. Cartilage, blood and bone are specialized forms of connective tissue. Maria Carmela L. Domocmat, RN, MSN
  • 11. Connective tissue is made up of dozens of proteins, including: collagens (a fibrous protein building block) proteoglycans (a group of proteins that maintain tissue stiffness) glycoproteins (composed of a protein and a sugar) The combination of these proteins can vary between tissues. Maria Carmela L. Domocmat, RN, MSN
  • 12. Connective tissue disorders (CTD) Is the major focus of rheumatology The study of rheumatic disease rheumatic disease is any disease or condition involving the musculoskeletal system CTDs are discussed separately from other musculoskeletal disorders bcoz most CTDs are classified as autoimmune disorders Maria Carmela L. Domocmat, RN, MSN
  • 13. Connective tissue disorders (CTD) Many rheumatic related Dermatomyositis conditions are also Polymyositis connective tissue disorders Bursitis including: Vasculitis Lupus (Systemic Lupus Erythematosus) Polymyalgia rheumatica Psoriasis Giant Cell Arteritis Scleroderma (Systemic Mixed Connective Tissue Sclerosis) Disease (MCTD) Ankylosing Spondylosis Lyme disease Reactive Arthritis Sarcoidosis Fibromyalgia Maria Carmela L. Domocmat, RN, MSN
  • 14. Rheumatic diseases or disorders Comprise autoimmune and inflammatory disorders ‗the primary crippling disease‖ Maria Carmela L. Domocmat, RN, MSN
  • 15. Rheumatic diseases or disorders Primary reason for work-related disability Leading cause of disability among 65 yrs old and above More than 40M in US have at least 1 of more than 100 types of arthritis Arthritis – means inflammation of one or more joints Maria Carmela L. Domocmat, RN, MSN
  • 16. Maria Carmela L. Domocmat, RN, MSN
  • 17.
  • 18. Rheumatoid Arthritis (RA) chronic systemic autoimmune disease - anti-self antibodies that react with the constant regions of other antibodies (rheumatoid factor) onset of disease occurs most often between the ages of 25-55 women are 3 times more likely to develop this than men symptoms include weakness, fatigue, and joint pain infections, hormones and genetic factors may be involved X-ray shows severe arthritis affecting the joints and limiting mobility Maria Carmela L. Domocmat, RN, MSN
  • 19. Rheumatoid arthritis (RA) affects peripheral joints and may cause destruction of both cartilage and bone. The disease affects mainly individuals carrying the DR4 variant of MHC genes. Maria Carmela L. Domocmat, RN, MSN
  • 20. Treatment Maria Carmela L. Domocmat, RN, MSN
  • 21. Maria Carmela L. Domocmat, RN, MSN
  • 22. Maria Carmela L. Domocmat, RN, MSN
  • 23. Maria Carmela L. Domocmat, RN, MSN
  • 24. ACR Clinical Classification Criteria for Rheumatoid Arthritis using history, physical examination, laboratory and radiographic findings: Maria Carmela L. Domocmat, RN, MSN
  • 25. ACR Clinical Classification Criteria for Rheumatoid Arthritis Maria Carmela L. Domocmat, RN, MSN
  • 26. Maria Carmela L. Domocmat, RN, MSN
  • 28. Maria Carmela L. Domocmat, RN, MSN
  • 29. Maria Carmela L. Domocmat, RN, MSN
  • 30. Maria Carmela L. Domocmat, RN, MSN
  • 31. Maria Carmela L. Domocmat, RN, MSN
  • 32. Maria Carmela L. Domocmat, RN, MSN
  • 33. Initial Laboratory work-up Complete blood count Comprehensive metabolic panel Urinalysis Sedimentation Rate Rheumatoid Factor Anti-nuclear Antibody Maria Carmela L. Domocmat, RN, MSN
  • 34. Maria Carmela L. Domocmat, RN, MSN
  • 35. Other diagnostic tests Radiologic exam X-ray, Bone scan or joint scan, MRI Help confirm disease activity and monitor treatment results Early stage: Increased shadowing around the affected joint: indicates soft tissue swelling Maria Carmela L. Domocmat, RN, MSN
  • 36. Radiology early in the disease show nothing other than soft tissue swelling. periarticular osteopenia may develop. With progression of disease narrowing of the joint space is caused by loss of cartilage, and juxta-articular erosions appear, generally at the point of attachment of the synovium. end-stage disease large cystic erosions of bone may be seen. Bony proliferation may occur because of degenerative changes that follow inflammation. Maria Carmela L. Domocmat, RN, MSN
  • 37. Other diagnostic tests Arthrocentesis Aspirate sample of synovial fluid; analyzed for inflam cells and immune complexes Synovial fluid is milky, cloudy, or dark yellow fluid (normal: transparent) Arthroscopic examination: show pale, thick, edematous synovial villi, cartilage destruction, and fibrous scar formation (pannus) Nrg care: use ice and rest the affected joint for 24 hrs Acetaminophen Maria Carmela L. Domocmat, RN, MSN
  • 38. Clinical manifestations Maria Carmela L. Domocmat, RN, MSN
  • 39. Maria Carmela L. Domocmat, RN, MSN
  • 41. Maria Carmela L. Domocmat, RN, MSN
  • 42. Maria Carmela L. Domocmat, RN, MSN
  • 43. Typical visible changes include ulnar deviation of the fingers at the MCP joints, hyperextension or hyperflexion of the MCP and PIP joints, flexion contractures of the elbows, and subluxation of the carpal bones and toes (cocked -up). Maria Carmela L. Domocmat, RN, MSN
  • 44. Extra-Articular Disease Rheumatoid Nodules Cardiopulmonary Disease Ocular Disease Neurologic Disease Felty's Syndrome Rheumatoid Vasculitis Sjogren's Syndrome Maria Carmela L. Domocmat, RN, MSN
  • 45. Rheumatoid Nodules subcutaneous nodule the most characteristic extra-articular lesion of the disease. occur in 20 to 30% of cases, almost exclusively in seropositive patients. located most commonly on the extensor surfaces of the arms and elbows but are also prone to develop at pressure points on the feet and knees. Maria Carmela L. Domocmat, RN, MSN
  • 46. Rheumatoid Nodules http://images.rheumatology.org/vi ewphoto.php?imageId=3011201 &albumId=75692 Maria Carmela L. Domocmat, RN, MSN
  • 47. Rheumatoid Nodules commonly form near extensor surface of elbow can be fixed to underlying periosteum or can be freely mobile. Maria Carmela L. Domocmat, RN, MSN
  • 48. Cardiopulmonary Disease There are several pulmonary manifestations including pleurisy with or without effusion, intrapulmonary nodules, rheumatoid pneumoconiosis (Caplan's syndrome), diffuse interstitial fibrosis, and rarely, bronchiolitis obliterans pneumothorax. Maria Carmela L. Domocmat, RN, MSN
  • 49. Caplan‘s Syndrome Presence of rheumatoid nodules in lungs pneumococcus (noted in among coal miners and asbestos workers) http://images.rheumatology. org/image_dir/album75692/ md_99-05-0096_1.tif.jpg Maria Carmela L. Domocmat, RN, MSN
  • 50. Cardiopulmonary Disease Pericarditis is the most common cardiac manifestation. Maria Carmela L. Domocmat, RN, MSN
  • 51. Neurologic Disease most common - mild, primarily sensory peripheral neuropathy, usually more marked in the lower extremities. Entrapment neuropathies (e.g., carpal tunnel syndrome and tarsal tunnel syndrome) sometimes occur because of compression of a peripheral nerve by inflamed edematous tissue. Maria Carmela L. Domocmat, RN, MSN
  • 52. Neurologic Disease Cervical myelopathy secondary to atlantoaxial subluxation (partial dislocation) is an uncommon but particularly worrisome complication potentially causing permanent, even fatal neurologic damage. Maria Carmela L. Domocmat, RN, MSN
  • 53. Felty's Syndrome is characterized by splenomegaly, leukopenia - predominantly Granulocytopenia and leg ulcers rare complication Recurrent bacterial infections and chronic refractory leg ulcers are the major complications. Maria Carmela L. Domocmat, RN, MSN
  • 54. Rheumatoid Vasculitis most common clinical manifestations a small digital infarcts along the nailbeds. Maria Carmela L. Domocmat, RN, MSN
  • 55. Sjogren's Syndrome • is the most common ocular manifestation of rheumatoid arthritis. Autoimmune destruction of the lacrimal, salivary and vaginal mucus producing glands which leads to impaired secretion of saliva and tears and results in the sicca complex: dry mouth (xerostomia) dry eyes (keratoconjunctivitis sicca) dry vagina (rare) Maria Carmela L. Domocmat, RN, MSN
  • 56. Sjogren's Syndrome Associated with RA and fibromyalgia Insufficient tears cause inflammation and ulceration of the cornea insufficient saliva cause decreased digestion of CHO, promotes tooth decay and increases incidence of infections Vaginal dryness cause infection and dyspareunia NO CURE!!! Maria Carmela L. Domocmat, RN, MSN
  • 57. Criteria for Diagnosis of Sjögren's Syndrome Four or more of the following criteria must be present Maria Carmela L. Domocmat, RN, MSN
  • 58. Keratoconjunctivitis, Sicca Maria Carmela L. Domocmat, RN, MSN
  • 59. PROGNOSIS Maria Carmela L. Domocmat, RN, MSN
  • 60. Disability is higher among patients with rheumatoid arthritis with 60% being unable to work 10 years after the onset of their disease. Recent studies have demonstrated an increased mortality in rheumatoid patients. Median life expectancy was shortened an average of 7 years for men and 3 years for women compared to control populations. Maria Carmela L. Domocmat, RN, MSN
  • 61. Patients at higher risk for shortened survival are those with systemic extra-articular involvement, low functional capacity, low socioeconomic status, low education, and prednisone use. Maria Carmela L. Domocmat, RN, MSN
  • 62. ACR Guidelines for Medical Management of Rheumatoid Arthritis (updated April, 2002)
  • 63. Maria Carmela L. Domocmat, RN, MSN
  • 64. Management Maria Carmela L. Domocmat, RN, MSN
  • 65. goals of treatment aim toward achieving the lowest possible level of arthritis disease activity and remission if possible, the minimization of joint damage, and enhancing physical function and quality of life. Maria Carmela L. Domocmat, RN, MSN
  • 66.  Reduce pain and inflammation  Protect Articular surface › Reduction of joint stress  Maintain function › ROM exercises › Physical and occupational therapy  Surgical intervention Maria Carmela L. Domocmat, RN, MSN
  • 67. REDUCE PAIN AND INFLAMMATION Maria Carmela L. Domocmat, RN, MSN
  • 68. Pharmacologic treatment 1. Non-steroidal Anti-inflammatory Agents (NSAIDs) 2. Disease Modifying Anti-rheumatic Drugs (DMARDs) 3. Corticosteroids Maria Carmela L. Domocmat, RN, MSN
  • 69. NSAIDs and corticosteroids have a short onset of action while DMARDs can take several weeks or months to demonstrate a clinical effect Maria Carmela L. Domocmat, RN, MSN
  • 70. NON-STEROIDAL ANTI- INFLAMMATORY AGENTS (NSAIDS) Maria Carmela L. Domocmat, RN, MSN
  • 71. NSAIDs major effect - reduce acute inflammation thereby decreasing pain and improving function. have mild to moderate analgesic properties independent of their anti-inflammatory effect. Note: these drugs alone do not change the course of the disease of rheumatoid arthritis or prevent joint destruction. Maria Carmela L. Domocmat, RN, MSN
  • 72. OTC NSAIDs Aspirin ibuprofen (Advil ®, Motrin®, Nuprin ®) naproxen (Alleve®, Flanax) ketoprofen (Actron, Orudis KT) Maria Carmela L. Domocmat, RN, MSN
  • 73. Aspirin - oldest drug of the non-steroidal class but because of its high rate of GI toxicity, a narrow window between toxic and anti-inflammatory serum levels, and the inconvenience of multiple daily doses, aspirin's use as the initial choice of drug therapy has largely been replaced by other NSAIDs. Maria Carmela L. Domocmat, RN, MSN
  • 74. Prescription NSAIDs include meloxicam (Mobic®), diclofenac (Cataflam®, etodolac (Lodine®), Voltaren®, Arthrotec®), nabumetone (Relafen®), diflusinal (Dolobid®), sulindac (Clinoril®), indomethicin (Indocin®), tolementin (Tolectin®), ketoprofen (Orudis®, choline magnesium Oruvail®), salicylate (Trilasate®), oxaprozin (Daypro®), flurbiprofen (Ansaid), piroxicam (Feldene®). dexibuprofen (Seractil) Maria Carmela L. Domocmat, RN, MSN
  • 75. Beware of NSAID-induced ulcers Maria Carmela L. Domocmat, RN, MSN
  • 76. How to Prevent NSAID-Induced Ulcers If NSAID-induced ulcers are identified, the following steps have been suggested: Switch to alternative pain relievers. proton-pump inhibitors (PPIs). misoprostol or Arthrotec. L-arginine If cannot change drugs, then should use lowest NSAID dose possible Maria Carmela L. Domocmat, RN, MSN
  • 77. Prevention NSAID-Induced Ulcers proton-pump inhibitors (PPIs). Can reduce NSAID-ulcer rates by as much as 80% compared with no treatment. omeprazole (Prilosec) esomeprazole (Nexium) lansoprazole (Prevacid), rabeprazole (Aciphex), pantoprozole (Protonix). Maria Carmela L. Domocmat, RN, MSN
  • 78. Prevention NSAID-Induced Ulcers Try misoprostol or Arthrotec. If other agents are inappropriate, misoprostol protects against the major intestinal toxicity of NSAIDs. the first drug approved for preventing NSAID-induced ulcers. It is equally or even more effective than some of the PPIs, but it does not heal existing ulcers and has more side effects than PPIs. Patients tend to stop using it. Arthrotec - a combination of an ulcer protective agent called misoprostol and the NSAID diclofenac. Maria Carmela L. Domocmat, RN, MSN
  • 79. L-arginine supplement an amino acid found in health stores may help protect against damage from NSAIDs. an alternative agent not government regulated and more research is needed to confirm its benefits. Maria Carmela L. Domocmat, RN, MSN
  • 80. Topical NSAIDs delivered in gels, creams, or patches are proving to reduce arthritic pain and pose less of a risk for gastrointestinal complications associated with oral NSAIDs. diclofenac (Pennsaid, Oxa Sat) eltenac, ibuprofen, or ketoprofen. Maria Carmela L. Domocmat, RN, MSN
  • 81. $63.07 Maria Carmela L. Domocmat, RN, MSN
  • 82. NSAIDS: COX-2 inhibitor includes COX-2 inhibitors also effective in controlling inflammation. Only one of these agents is currently available in the United States (celecoxib, Celebrex®) while additional compounds are available in other countries (etoricoxib, Arcoxia®; lumiracoxib, Prexige®). Maria Carmela L. Domocmat, RN, MSN
  • 83. or COX-2 medications Maria Carmela L. Domocmat, RN, MSN
  • 84. COX-2 inhibitors designed to decrease the gastrointestinal risk of NSAIDS, but concerns of possible increases in cardiovascular risk with these agents has led to the withdrawal of two of these drugs from the market (rofecoxib, Vioxx®; valdecoxib, Bextra®). Maria Carmela L. Domocmat, RN, MSN
  • 85. CORTICOSTEROIDS Maria Carmela L. Domocmat, RN, MSN
  • 86. Corticosteroids anti-inflammatory & immunoregulatory activity. PO, IV, IM or can be injected directly into the joint. useful in early disease as temporary adjunctive therapy while waiting for DMARDs to exert their antiinflammatory effects. Maria Carmela L. Domocmat, RN, MSN
  • 87. Corticosteroids Maria Carmela L. Domocmat, RN, MSN
  • 88. Corticosteroids also useful as chronic adjunctive therapy in patients with severe disease that is not well controlled on NSAIDs and DMARDs. Weight gain and a cushingoid appearance (increased fat deposition around the face, redness of the cheeks, development of a ―buffalo hump‖ over the neck) is a frequent problem and source of patient complaints Maria Carmela L. Domocmat, RN, MSN
  • 89. cushingoid appearance Maria Carmela L. Domocmat, RN, MSN
  • 90. Prevent osteoporosis due to steroid use adequate calcium and vitamin D supplementation Bisphosphonates alendronate (Fosamax®) risedronate (Actonel®) ibandronate (Boniva®) Patients with and without osteoporosis risk factors on low dose prednisone should undergo bone densitometry (DEXA Scan) to assess fracture risk. Maria Carmela L. Domocmat, RN, MSN
  • 91. Intra-articular corticosteroids (e.g., triamcinolone or methylprednisolone and others) are effective for controlling a local flare in a joint without changing the overall drug regimen. Maria Carmela L. Domocmat, RN, MSN
  • 93. DISEASE MODIFYING ANTI- RHEUMATIC DRUGS (DMARDS) Maria Carmela L. Domocmat, RN, MSN
  • 94. Disease Modifying Anti-rheumatic Drugs (DMARDs) Can alter the disease course and improve radiographic outcomes. DMARDs have an effect upon rheumatoid arthritis that is different and may be more delayed in onset than either NSAIDs or corticosteroids. when the diagnosis of rheumatoid arthritis is confirmed, DMARD agents should be started. Maria Carmela L. Domocmat, RN, MSN
  • 95. DMARDs Methotrexate (Rheumatrex®, Trexall®) Hydroxychloroquine (Plaquenil ®) Sulfasalazine (Azulfidine®) Tumor Necrosis Factor Inhibitors etanercept (Enbrel® adalimumab (Humira ®) infliximab (Remicade®) Leflunomide (Arava®) T-cell Costimulatory Blocking Agents abatacept (Orencia®) Maria Carmela L. Domocmat, RN, MSN
  • 96. DMARDs B cell Depleting Agents rituximab (Rituxan®) Interleukin-1 (IL-1) Receptor Antagonist Therapy anakinra (Kineret®) Intramuscular Gold Other Immunomodulatory and Cytotoxic agents— azathioprine (Imuran®), cyclophosphamide, and cyclosporine A(Neoral®, Sandimmune®) Maria Carmela L. Domocmat, RN, MSN
  • 97. Nursing Mgmt Note: DMARDs are toxic to multiple body organs including liver, kidneys, GIT, lungs, bone marrow, eyes, and must be monitored closely These drugs suppress the bone marrow and place clients at risk for infection, anemia, and bleeding Maria Carmela L. Domocmat, RN, MSN
  • 98. Methotrexate the first-line DMARD agent Has rapid onset of action at therapeutic doses (6- 8 weeks) good efficacy favorable toxicity profile ease of administration and relatively low cost. Maria Carmela L. Domocmat, RN, MSN
  • 100. Hydroxychloroquine an antimalarial drug relatively safe and well-tolerated agent for the treatment of rheumatoid arthritis. have limited ability to prevent joint damage on their own, their use should probably be limited to patients with very mild and nonerosive disease. Maria Carmela L. Domocmat, RN, MSN
  • 101. Hydroxychloroquine is sometimes combined with methotrexate for additive benefits for signs and symptoms or as part of a regimen of ―triple therapy‖ with methotrexate and sulfasalazine. Maria Carmela L. Domocmat, RN, MSN
  • 102. Sulfasalazine Azulfidine® effectiveness - somewhat less than that methotrexate, reduce signs and symptoms and slow radiographic damage. given in conjunction with methotrexate and hydroxychloroquine as part of a regimen of ―triple therapy‖ Maria Carmela L. Domocmat, RN, MSN
  • 103. Leflunomide (Arava®) efficacy is similar to methotrexate in terms of signs and symptoms viable alternative - failed or are intolerant to methotrexate. Maria Carmela L. Domocmat, RN, MSN
  • 104. Tumor necrosis factor (TNF) inhibitors Tumor necrosis factor alpha (TNF) is a pro-inflammatory cytokine produced by macrophages and lymphocytes. found in large quantities in the rheumatoid joint and is produced locally in the joint by synovial macrophages and lymphocytes infiltrating the joint synovium. TNF is one of the critical cytokines that mediate joint damage and destruction due to its activities on many cells in the joint as well as effects on other organs and body systems. Maria Carmela L. Domocmat, RN, MSN
  • 105. TNF antagonists first of the biological DMARDS to be approved for the treatment of RA have also been referred to as biological response modifiers or “biologics” to differentiate them from other DMARDS such as methotrexate, leflunomide, or sulfasalazine. Maria Carmela L. Domocmat, RN, MSN
  • 106. TNFs or Biological Response Modifiers (BRMs) Etanercept (Enbrel®) Infliximab(Remicade®) Adalimumab (Humira®) Maria Carmela L. Domocmat, RN, MSN
  • 107. Etanercept (Enbrel®) Etanercept is effective in reducing the signs and symptoms of RA, as well as in slowing or halting radiographic damage, when used either as monotherapy or in combination with methotrexate. Maria Carmela L. Domocmat, RN, MSN
  • 108. Infliximab(Remicade®) Infliximab, in combination with methotrexate, is approved for the treatment of RA, and for the treatment of psoriatic arthritis, and ankylosing spondylitis, as well as psoriasis and Crohn‘s disease. Maria Carmela L. Domocmat, RN, MSN
  • 109. Adalimumab (Humira®) Adalimumab is a fully human anti-TNF monoclonal antibody with high specificity for TNF. Maria Carmela L. Domocmat, RN, MSN
  • 110. Anakinra (Kineret™) a human recombinant IL-1 receptor antagonist (hu rIL-1ra) can be used alone or in combination with DMARDs other than TNF blocking agents (Etanercept, Infliximab, Adalimumab). Maria Carmela L. Domocmat, RN, MSN
  • 111. T-cell Costimulatory blockade Abatacept (Orencia®) first of a class of agents known as T-cell costimulatory blockers. interfere with the interactions between antigen- presenting cells and T lymphocytes and affect early stages in the pathogenic cascade of events in rheumatoid arthritis. Maria Carmela L. Domocmat, RN, MSN
  • 112. Intramuscular Gold Myochrysine® and Solganal® IM have been replaced by Methotrexate and other DMARDS as the preferred agents to treat RA. rarely used now due to their numerous side effects and monitoring requirements, their limited efficacy, and very slow onset of action. Maria Carmela L. Domocmat, RN, MSN
  • 113. Plasmapheresis Maria Carmela L. Domocmat, RN, MSN
  • 114. Alternative treatments glucosamine sulfate chondroitin sulfate are dietary supplements usually taken in pill form that are thought to protect and possibly help repair cartilage cells. Maria Carmela L. Domocmat, RN, MSN
  • 115. NURSING MANAGEMENT Maria Carmela L. Domocmat, RN, MSN
  • 116. Chronic pain r/t inflammation and swelling from pressure on surrounding tissues, joint deformity and joint destruction Teach about meds Promote comfort with nonpharmacologic measures Manage stiffness Promote sleep and rest Maria Carmela L. Domocmat, RN, MSN
  • 117. Promote comfort with nonpharmacologic measures Maria Carmela L. Domocmat, RN, MSN
  • 118. Manage stiffness Maria Carmela L. Domocmat, RN, MSN
  • 119. Promote sleep and rest Encourage to sleep at least 8 hrs at night, take daily naps Promote a quiet envt Provide warm beverages before retiring to sleep Administer hypnotics or relaxants as prescribed Maria Carmela L. Domocmat, RN, MSN
  • 120. REDUCTION OF JOINT STRESS Maria Carmela L. Domocmat, RN, MSN
  • 121. Reduction of joint stress Because obesity stresses the musculoskeletal system, ideal body weight should be achieved and maintained. Rest, in general, is an important feature of management. When the joints are actively inflamed, vigorous activity should be avoided because of the danger of intensifying joint inflammation or causing traumatic injury to structures weakened by inflammation. Maria Carmela L. Domocmat, RN, MSN
  • 122. Readiness for enhanced self-care r/t complex medication schedules, high risk of S/E of meds, health maintenance, and self-care Promote balanced diet Promote decision-making Promote hope Promote coping Maria Carmela L. Domocmat, RN, MSN
  • 123. Self-care Use china or heavy plastic cup with handle which is easier to manipulate rather than styrofoam or paper cup which may bend or collapse When fine motor activities become impossible – use larger joints or body surfaces Ex: use palm of hand to press the toothpaste to toothbrush rather than the fingers Use devices – long-handed brushes to brush hair or dressing sticks for facilitite wearing of pants Maria Carmela L. Domocmat, RN, MSN
  • 124. Reduction of joint stress urge to maintain a modest level of activity to prevent joint laxity and muscular atrophy. Splinting of acutely inflamed joints, particularly at night and the use of walking aids (canes, walkers) are all effective means of reducing stress on specific joints. Maria Carmela L. Domocmat, RN, MSN
  • 125. Assistive devices Computer Keyboard Aid Arthritic's Pen Maria Carmela L. Domocmat, RN, MSN
  • 126. Phone & Cup Holder with Hook and Loop Strap Maria Carmela L. Domocmat, RN, MSN
  • 127. Arthritis in your hands causes your finger joints and knuckles to become stiff and sometimes painful and swollen. Protect your hands by avoiding pushing, pulling and twisting motions. Avoid making a tight fist or pinching objects tightly. Maria Carmela L. Domocmat, RN, MSN
  • 128. Instead, use a grasp that aligns your knuckles evenly along the handle of the tool or utensil. This makes grasping the tool more comfortable and requires less effort to use the tool. For instance, a built-up handle made of foam can make it easier for you to grasp your toothbrush. Maria Carmela L. Domocmat, RN, MSN
  • 129. For tasks that require to pinch objects tightly, look for assistive devices that can help hold the object with less force. special key holder may help turn keys more comfortably without putting strain on hand. This type of holder aligns knuckles evenly along the handle of the tool or utensil, allow use a larger grip to turn the key. Maria Carmela L. Domocmat, RN, MSN
  • 130. Use assistive devices to help you open jars. This spares your fingers from the twisting motion required to open a jar. Maria Carmela L. Domocmat, RN, MSN
  • 131. To protect your finger joints, avoid tightly pinching with your fingers. For example, use a button aid to help you grasp and fasten buttons on your clothes. Choose clothes with easy-to-close fasteners, such as zippers, large buttons or hooks. Maria Carmela L. Domocmat, RN, MSN
  • 132. Promote balanced diet Good oral hygiene b4 and after meals Small, frequent feedings High-caloric snacks If with xerostamia – moisten foods, extra fluids with meals Eliminate spicy or acidic foods Sit upright to eat Take all meds with food and full glass of water – to ameliorate GI distress Use assistive device if with stiffness Maria Carmela L. Domocmat, RN, MSN
  • 133. Sjogren‘s syndrome mgmt Symptomatic treatment Artificial tears and saliva Lubricants Moisturizers Systemic pilocarpine – for dry mouth Blockade of tear outflow NSAIDS – for pain Maria Carmela L. Domocmat, RN, MSN
  • 134. Promote decision-making Exercise healthy control over the disease Client should be able to verbalize cause of illness Educate the client Increase participation in decision-making allow as many choices as possible Decide on own ADL Maria Carmela L. Domocmat, RN, MSN
  • 135. Promote hope Avoid false reassurance Help set realistic goals Praise for accomplishments (no matter how small) Active listening Be sensitive to changes in mind and affect Maria Carmela L. Domocmat, RN, MSN
  • 136. Promote coping The client would be able to integrate disease into the demands of daily living Sign that the client has healthy approach strategies Seek out info and assistance Find strength through spiritual support Verbalize feelings and concerns Set goals Express positive thoughts Maintain realistic independence Maria Carmela L. Domocmat, RN, MSN
  • 137. Signs of less adaptive strategies Avoidance strategies – ex: denial Excessive sleeping Other passive behaviors Depression Maria Carmela L. Domocmat, RN, MSN
  • 138. FATIGUE Maria Carmela L. Domocmat, RN, MSN
  • 139. Management of Fatigue: For muscle atrophy – aggressive PT to strengthen muscle and prevent further atrophy Maria Carmela L. Domocmat, RN, MSN
  • 140. Management of Fatigue Principles of energy conservation Pacing activities- do not plan too much activity for one day Allow rest periods Set priorities – determine which activities are most important and do them first Obtain assistance when needed – delegate responsibilities balance activity and rest Plan ahead to prevent last minute rushing and stress Learn own activity tolerance and do not exceed it Maria Carmela L. Domocmat, RN, MSN
  • 141. BODY IMAGE DISTURBANCE Maria Carmela L. Domocmat, RN, MSN
  • 142. Enhance body image Body image may be affected by both the disease process and drug therapy Ulnar deviation, swan-neck deformity, boutonnière deformity, rheumatoid nodules Steroid side effect – cushingoid syndrome Determine client‘s perception of the changes and impact of reaction of the SO Most impt Ix – communicate acceptance of the client ; establish and maintain trusting relationship to encourage the client to express feelings Maria Carmela L. Domocmat, RN, MSN
  • 143. Let the client wear own clothes rather than the hosp gown, brush own hair, use make-up if desired Use colored hair accessories , nail polish, perfume Maria Carmela L. Domocmat, RN, MSN
  • 144. SURGICAL INTERVENTIONS Maria Carmela L. Domocmat, RN, MSN
  • 145. Surgical interventions Tendon transfer and osteotomy Synovectomy Arthrodesis Joint arthroplasty or replacement Maria Carmela L. Domocmat, RN, MSN
  • 146. Tendon transfer and osteotomy Nodules or benign bony tumors (exostoses) – surgically removed and flexion contractures surgically relieved Osteotomies Excision or cutting through bones Maria Carmela L. Domocmat, RN, MSN
  • 147. Synovectomy Surgical removal of synovia – elbow, wrist, fingers, knees Maria Carmela L. Domocmat, RN, MSN
  • 148. Synovectomy ordinarily not recommended for patients with rheumatoid arthritis, primarily because relief is only transient. synovectomy of the wrist - an exception recommended if intense synovitis is persistent despite medical treatment over 6 to 12 months. Persistent synovitis involving the dorsal compartments of the wrist can lead to extensor tendon sheath rupture resulting in severe disability of hand function. Maria Carmela L. Domocmat, RN, MSN
  • 149. Synovectomy Maria Carmela L. Domocmat, RN, MSN
  • 150. Maria Carmela L. Domocmat, RN, MSN
  • 151. Arthrodesis Operation that produce bony fusion of joint used for clients with bone loss after joint infection , tumors, musculoskeletal trauma, paralysis Immobilize the joint but eliminate some discomfort or arthritic process Ankle - most common Maria Carmela L. Domocmat, RN, MSN
  • 152. Joint arthroplasty or replacement particularly of the knee, hip, wrist, and elbow, are highly successful. Arthroplasty of the metacarpophalangeal (knuckle) joints also can reduce pain and improve function. Maria Carmela L. Domocmat, RN, MSN
  • 153. Hip Replacement Maria Carmela L. Domocmat, RN, MSN
  • 154. Maria Carmela L. Domocmat, RN, MSN
  • 155. Surgical intervention Maria Carmela L. Domocmat, RN, MSN
  • 156. Surgical intervention Other operations include release of nerve entrapments (e.g., carpal tunnel syndrome) arthroscopic procedures removal of a symptomatic rheumatoid nodule Maria Carmela L. Domocmat, RN, MSN
  • 157. Complementary/ Alternative therapies Pain relief – hypnosis, acupuncture, magnet Good nutrition Omega-3 fatty acids Found in coldwater fish (salmon, sea bass, tuna) May help reduce inflam But amount needed is impractical to human consumption Fish oil capsules Maria Carmela L. Domocmat, RN, MSN
  • 158. Complementary/ Alternative therapies Antioxidant vitamins (A,C, E) to help maintain normal function of the immune system Trace elements for joint health Zinc, Selenium, Copper, Iron Maria Carmela L. Domocmat, RN, MSN
  • 159.
  • 160. Osteoarthritis associated with the aging process and can affect any joint. The cartilage of the affected joint is gradually worn down, eventually causing bone to rub against bone. Bony spurs develop on the unprotected bones, causing pain and inflammation. Bouchard‘s nodes Maria Carmela L. Domocmat, RN, MSN
  • 161. WHAT’S THE DIFFERENCE BETWEEN RA AND OA? Maria Carmela L. Domocmat, RN, MSN
  • 162. Maria Carmela L. Domocmat, RN, MSN
  • 163. Osteoarthritis is a deterioration of cartilage and overgrowth of bone often due to "wear and tear." Rheumatoid arthritis is the inflammation of a joint's connective tissues, such as the synovial membranes, which leads to the destruction of the joint's cartilage. Maria Carmela L. Domocmat, RN, MSN
  • 164. Known as the ―wear-and-tear‖ kind of arthritis a chronic condition characterized by the breakdown of the joint‘s cartilage. Cartilage is the part of the joint that cushions the ends of the bones and allows easy movement of joints. The breakdown of cartilage causes the bones to rub against each other, causing stiffness, pain and loss of movement in the joint. Maria Carmela L. Domocmat, RN, MSN
  • 165. AKA degenerative joint disease, ostoarthrosis, hypertrophic arthritis degenerative arthritis. Maria Carmela L. Domocmat, RN, MSN
  • 166. stages of osteoarthritis Cartilage loses elasticity and is more easily damaged by injury or use. Wear of cartilage causes changes to underlying bone. The bone thickens and cysts may occur under the cartilage. Bony growths, called spurs or osteophytes, develop near the end of the bone at the affected joint. Maria Carmela L. Domocmat, RN, MSN
  • 167. stages of osteoarthritis Bits of bone or cartilage float loosely in the joint space. The joint lining, or the synovium, becomes inflamed due to cartilage breakdown causing cytokines (inflammation proteins) and enzymes that damage cartilage further. Maria Carmela L. Domocmat, RN, MSN
  • 168. The main problem in knee OA is degeneration of the articular cartilage. Articular cartilage is the smooth lining that covers the ends of bones where they meet to form the joint. The cartilage gives the knee joint freedom of movement by decreasing friction. Maria Carmela L. Domocmat, RN, MSN
  • 169. The articular cartilage is kept slippery by joint fluid made by the joint lining (the synovial membrane). The fluid, called synovial fluid, is contained in a soft tissue enclosure around synovial joints called the joint capsule. Maria Carmela L. Domocmat, RN, MSN
  • 170. An important substance present in articular cartilage and synovial fluid is called hyaluronic acid. Hyaluronic acid helps joints collect and hold water, improving lubrication and reducing friction. It also acts by allowing cells to move and work within the joint. Maria Carmela L. Domocmat, RN, MSN
  • 171. When the articular cartilage degenerates, or wears away, the bone underneath is uncovered and rubs against bone. Small outgrowths called bone spurs, or osteophytes, may form in the joint. Maria Carmela L. Domocmat, RN, MSN
  • 172. Changes in the cartilage and bones of the joint can lead to pain, stiffness and use limitations. Deterioration of cartilage can: Affect the shape and makeup of the joint so it doesn‘t function smoothly. - limp when walk or have trouble going up and down stairs. Cause fragments of bone and cartilage to float in joint fluid causing irritation and pain. Cause bony spurs, called osteophytes, to develop near the ends of bones Mean the joint fluid doesn‘t have enough hyaluronan, which affects the joint‘s ability to absorb shock. Maria Carmela L. Domocmat, RN, MSN
  • 173. Maria Carmela L. Domocmat, RN, MSN
  • 174. Causes and Risk factors there is no single known cause of osteoarthritis (OA), there are several risk factors that should be considered Age Obesity Injury or Overuse Genetics or Heredity Muscle Weakness Other Diseases and Types of Arthritis Maria Carmela L. Domocmat, RN, MSN
  • 175. Maria Carmela L. Domocmat, RN, MSN
  • 176. Treatment Acetaminophen Nonsteroidal anti-inflammatory drugs (NSAIDs) or COX-2 medications Capsaicin Tramadol Narcotic pain relievers glucosamine sulfate and chondroitin sulfate Maria Carmela L. Domocmat, RN, MSN
  • 177. Acetaminophen Tylenol, Anacin-3, Panadal, Phenaphen, Valadol, and others) for mild to moderate osteoarthritis. usually the first choice Maria Carmela L. Domocmat, RN, MSN
  • 178. Nonsteroidal anti-inflammatory drugs (NSAIDs) for moderate to severe arthritic pain. OTC NSAIDs Prescription NSAIDs include Maria Carmela L. Domocmat, RN, MSN
  • 179. Drugs for Prevention NSAID- Induced Ulcers If NSAID-induced ulcers are identified switch to alternative pain relievers. Maria Carmela L. Domocmat, RN, MSN
  • 180. Topical NSAIDs $63.07 Maria Carmela L. Domocmat, RN, MSN
  • 181. Capsaicin (Zostrix) is an ointment prepared from the active ingredient in hot chili peppers that has been helpful for relieving painful areas in other disorders. Maria Carmela L. Domocmat, RN, MSN
  • 182. SALONPAS PAIN PATCH WITH CAPSAICIN Maria Carmela L. Domocmat, RN, MSN
  • 183. Tramadol (Ultram) is a pain reliever that has some properties that are similar to narcotics. not as addictive, however, and may be an alternative for patients who do not respond to NSAIDs or less potent agents. Maria Carmela L. Domocmat, RN, MSN
  • 184. Maria Carmela L. Domocmat, RN, MSN
  • 185. Narcotic pain relievers oxycodone, oxymorphone, or morphine may be necessary for severe pain that does not respond to less potent pain relievers. Maria Carmela L. Domocmat, RN, MSN
  • 187. Management Same with RA Maria Carmela L. Domocmat, RN, MSN
  • 189. Maria Carmela L. Domocmat, RN, MSN
  • 190. Gouty arthritis is a disease characterized by an abnormal metabolism of uric acid, resulting in an excess of uric acid in the tissues and blood causing inflammation People with gout either produce too much uric acid, or more commonly, their bodies have a problem in removing it. AKA gout the disease of kings the king of diseases Maria Carmela L. Domocmat, RN, MSN
  • 191. Gouty arthritis 2 major types Primary Secondary Maria Carmela L. Domocmat, RN, MSN
  • 192. Gouty arthritis Primary Inherited X-lined trait Caused by several inborn errors of purine metabolism Uric acid- is the end-product of purine metabolism; excreted in urine Production of uric acid exceeds the excretion capability of kidneys Sodium urate is deposited in the synovium and other tissues which results in inflammation Males, 30‘s and 40‘s Maria Carmela L. Domocmat, RN, MSN
  • 193. Gouty arthritis Secondary Hyperuricemia Excessive uric acid in blood casued by anoterh disease Affects all ages Renal insufficiency Diuretic therapy Multiple myeloma Carcinomas Causes: decreased normal excretion of uric acid and other waste products Increased production of uric acid Maria Carmela L. Domocmat, RN, MSN
  • 194. Four Stages Of Gouty Arthritis Asymptomatic Hyperuricemia Acute Gout / Acute Gouty Arthritis Interval / Intercritical Chronic Tophaceous Gout Maria Carmela L. Domocmat, RN, MSN
  • 195. Four Stages Of Gouty Arthritis Asymptomatic Hyperuricemia: Asypmptomatic but with elevated blood uric acid levels Serum uric acid level (mg/dl) Incidence of gout >9.0 7.0-8.9 7.0-8.9 0.5-0.37 <7.0 0.1% Maria Carmela L. Domocmat, RN, MSN
  • 196. Four Stages Of Gouty Arthritis Acute Gout / Acute Gouty Arthritis hyperuricemia has caused deposits of uric acid crystals in joint spaces, leading to gouty attacks. Excruciating pain and inflammation of one or more joints – esp metatarsophalangeal joints of the great toe (podagra) Increased ESR, WBC Maria Carmela L. Domocmat, RN, MSN
  • 197. Maria Carmela L. Domocmat, RN, MSN
  • 200. Four Stages Of Gouty Arthritis Interval / Intercritical the periods between acute gouty attacks – may be months or years after the 1st attack Asymptomatic period No abnormality in joints Chronic Tophaceous Gout: the disease has caused permanent damage Deposits or urate crytals under skin and within major organs (i.e., urate kidney stone formation) Maria Carmela L. Domocmat, RN, MSN
  • 201. Tophi Tophi – deposits of sodium urate crystals May occur anywhere; common in outer ear http://www.hopkins-arthritis.org/images/gout_fig7.gif Maria Carmela L. Domocmat, RN, MSN
  • 204. http://img.medscape.com/slide/migr ated/editorial/cmecircle/2004/3689/i mages/cohen/slide019.gif Maria Carmela L. Domocmat, RN, MSN
  • 205. http://msnbcmedia1.msn.com/i/ms nbc/Components/Interactives/Healt h/MiscHealth/GOUT.gif Maria Carmela L. Domocmat, RN, MSN
  • 207. Dx tests Synovial fluid analysis (shows uric acid crystals) Uric acid - blood Joint x-rays (may be normal) Synovial biopsy Uric acid - urine Maria Carmela L. Domocmat, RN, MSN
  • 208. Maria Carmela L. Domocmat, RN, MSN
  • 209. Management Drug therapy Diet therapy Maria Carmela L. Domocmat, RN, MSN
  • 210. Management Drug therapy acute gouty arthritis – inflammation subsides spontaneously within 3 to 5 days But if cannot tolerate pain Colchicine (Colsalide, Novocolchicine) and NSAIDs Taken for 4-7 days (NSAIDs) -Indomethacin (Indocin), ibuprofen (Advil), and naproxen (Aleve), celecoxib (Celebrex) painkillers such as codeine, hydrocodone, and oxycodone Corticosteroids Maria Carmela L. Domocmat, RN, MSN
  • 211. Management Drug therapy Chronic or repeated acute episodes Allopurinol (Zyloprim) A xanthine oxidase inhibitor – prevents conversion of xanthine to uric acid Probenecid (Benemid, Benuryl) Uricosuric drug – promotes excretion of excess uric acid drink at least 2 liters of fluid a day while taking this medication (to help prevent uric acid kidney stones from forming). Combination drug Probenecid and Colchicine (ColBenemid) Note: avoid aspirin – it inactivates the drug Maria Carmela L. Domocmat, RN, MSN
  • 212. Maria Carmela L. Domocmat, RN, MSN
  • 213. Febuxostat (Uloric) first new medication developed specifically for the control of gout in over 40 years. Decreases formation of uric acid by the body and is a very reliable way to lower the blood uric acid level. can be used in patients with mild to moderate kidney impairment. should not be taken with 6-mercaptopurine (6-MP), or azathioprine. http://www.emedicinehealth.com/gout/page7_em.htm#Medications Maria Carmela L. Domocmat, RN, MSN
  • 214. Maria Carmela L. Domocmat, RN, MSN
  • 215. Management Diet therapy Avoid alcohol, anchovies, sardines, oils, herring, organ meat (liver, kidney, and sweetbreads), legumes (dried beans and peas), gravies, mushrooms, spinach, asparagus, cauliflower, consommé, and baking or brewer's yeast. http://www.ncbi.nlm.nih.gov/pubmedhealth/PMH0001459/ Maria Carmela L. Domocmat, RN, MSN
  • 216. Limit meat Avoid fatty foods such as salad dressings, ice cream, and fried foods. Eat enough carbohydrates. If losing weight, lose it slowly. Quick weight loss may cause uric acid kidney stones to form. http://www.ncbi.nlm.nih.gov/pubmedhealth/PMH0001459/ Maria Carmela L. Domocmat, RN, MSN
  • 217. http://s1.hubimg.com/u/1184832_f496.jpg Maria Carmela L. Domocmat, RN, MSN
  • 218. Avoid all forms of aspirin and diuretics – may precipitate attack Excessive physical or emotional stress- can exacerbate disease Maria Carmela L. Domocmat, RN, MSN
  • 219. Prevention of kidney stone formation Increase fluid intake – prevent stone formation Dilute urine and prevent sediment formation Alkaline ash diet Citrus fruits, juices, milk and certain dairy products Uric acid is more soluble in high pH urine – less likely to form urinary stones Maria Carmela L. Domocmat, RN, MSN
  • 220. Complications Chronic gouty arthritis Kidney stones Deposits in the kidneys, leading to chronic kidney failure Maria Carmela L. Domocmat, RN, MSN